منابع

بروشور FDA (DailyMed)

• FDA Amoxicillin — Amoxicillin tablets, for oral suspension, chewable tablets and capsules — Prescribing Information (SPL effective 2026-10-06, version 4)↗[عمومی]
• FDA Augmentin — AUGMENTIN (amoxicillin/clavulanate potassium) tablets, powder for oral suspension and chewable tablets — Prescribing Information (SPL effective 2016-09-01, version 6)↗[عمومی]
• FDA Augmentin ES-600 — AUGMENTIN ES-600 (amoxicillin/clavulanate potassium) for oral suspension — Prescribing Information (SPL effective 2026-07-07, version 6)↗[عمومی]
• FDA Zithromax — ZITHROMAX (azithromycin) tablets and oral suspension — Prescribing Information (SPL effective 2026-07-24, version 49)↗[عمومی]
• FDA Risperdal — RISPERDAL (risperidone) tablets, oral solution and M-TAB orally disintegrating tablets — Prescribing Information (SPL effective 2026-05-28, version 45)↗[عمومی]
• FDA Lactulose — Lactulose Solution USP (10 g/15 mL), Rx — Prescribing Information (SPL effective 2026-08-17, version 1)↗[عمومی]
• FDA Ibuprofen Rx — Ibuprofen Oral Suspension USP 100 mg/5 mL, Rx only — Prescribing Information (SPL effective 2026-03-30, version 1)↗[عمومی]
• FDA Ibuprofen OTC — Children's Ibuprofen Oral Suspension USP 100 mg/5 mL — Drug Facts (SPL effective 2026-07-15, version 1)↗[عمومی]
• FDA Cetirizine OTC — Children's Cetirizine Hydrochloride Oral Solution 5 mg/5 mL — Drug Facts (SPL effective 2026-09-25, version 4)↗[عمومی]
• FDA Guaif-Codeine OTC — Guaifenesin and Codeine Phosphate oral solution — Drug Facts (SPL effective 2026-06-02, version 5)↗[عمومی]
• FDA Cephalexin — Cephalexin for oral suspension — Prescribing Information (SPL effective 2026-09-02, version 1)↗[عمومی]
• FDA Cefixime — Cefixime for oral suspension and capsules — Prescribing Information (SPL effective 2025-10-14, version 14)↗[عمومی]
• FDA Cefuroxime susp — Cefuroxime axetil for oral suspension — Prescribing Information (SPL effective 2013-08-19, version 1)↗[عمومی]
• FDA Clarithromycin susp — Clarithromycin for oral suspension — Prescribing Information (SPL effective 2023-09-13, version 15)↗[عمومی]
• FDA Clarithromycin tab — Clarithromycin tablets — Prescribing Information (SPL effective 2025-06-09, version 15)↗[عمومی]
• FDA Cleocin Pediatric — CLEOCIN PEDIATRIC (clindamycin palmitate HCl) granules for oral solution — Prescribing Information (SPL effective 2026-06-01, version 35)↗[عمومی]
• FDA Erythromycin ES — Erythromycin ethylsuccinate for oral suspension — Prescribing Information (SPL effective 2025-06-20, version 3)↗[عمومی]
• FDA TMP-SMX susp — Sulfamethoxazole and trimethoprim oral suspension — Prescribing Information (SPL effective 2026-04-06, version 7)↗[عمومی]
• FDA Famotidine susp — Famotidine for oral suspension 40 mg/5 mL — Prescribing Information (SPL effective 2026-08-04, version 1)↗[عمومی]
• FDA Alinia — ALINIA (nitazoxanide) tablets and oral suspension — Prescribing Information (SPL effective 2024-03-20, version 10)↗[عمومی]
• FDA Ondansetron — Ondansetron tablets — Prescribing Information (SPL effective 2026-10-12, version 14)↗[عمومی]
• FDA Children's Benadryl — Children's Benadryl Allergy (diphenhydramine HCl 12.5 mg/5 mL) — Drug Facts (SPL effective 2026-09-11, version 15)↗[عمومی]
• FDA Loratadine OTC — Children's Allergy Relief (loratadine 5 mg/5 mL oral solution) — Drug Facts (SPL effective 2026-09-04, version 4)↗[عمومی]
• FDA Fexofenadine OTC — Fexofenadine HCl 30 mg/5 mL oral suspension — Drug Facts (SPL effective 2026-09-01, version 1)↗[عمومی]
• FDA Hydroxyzine — Hydroxyzine hydrochloride tablets — Prescribing Information (SPL effective 2026-10-09, version 1)↗[عمومی]
• FDA Desloratadine — Desloratadine tablets 5 mg — Prescribing Information (SPL effective 2026-04-16, version 12)↗[عمومی]
• FDA Children's Tylenol — Children's Tylenol (acetaminophen 160 mg/5 mL oral suspension) — Drug Facts (SPL effective 2026-06-12, version 3)↗[عمومی]
• FDA Mefenamic acid — Mefenamic acid capsules 250 mg — Prescribing Information (SPL effective 2026-04-20, version 13)↗[عمومی]
• FDA Theophylline sol — Theophylline Oral Solution 80 mg/15 mL — Prescribing Information (SPL effective 2026-02-06, version 4)↗[عمومی]
• FDA Nystatin susp — Nystatin Oral Suspension 100,000 units/mL — Prescribing Information (SPL effective 2026-10-09, version 4)↗[عمومی]
• FDA Metronidazole — Metronidazole tablets — Prescribing Information (SPL effective 2026-09-10, version 10)↗[عمومی]
• FDA Dicyclomine — Dicyclomine hydrochloride tablets — Prescribing Information (SPL effective 2026-10-13, version 1)↗[عمومی]
• FDA Oseltamivir susp — Oseltamivir phosphate for oral suspension 6 mg/mL — Prescribing Information (SPL effective 2026-10-06, version 14)↗[عمومی]
• FDA Emverm — EMVERM (mebendazole) chewable tablet 100 mg — Prescribing Information (SPL effective 2021-08-23, version 11)↗[عمومی]
• FDA Albenza — ALBENZA (albendazole) tablets — Prescribing Information (SPL effective 2019-09-23, version 14)↗[عمومی]
• FDA Acyclovir susp — Acyclovir Oral Suspension 200 mg/5 mL — Prescribing Information (SPL effective 2026-01-23, version 4)↗[عمومی]
• FDA Montelukast — Montelukast sodium tablets, chewable tablets and oral granules — Prescribing Information (SPL effective 2026-07-28, version 24)↗[عمومی]
• FDA Ventolin HFA — VENTOLIN HFA (albuterol sulfate) inhalation aerosol — Prescribing Information (SPL effective 2026-09-24, version 15)↗[عمومی]
• FDA Permethrin 5% — Permethrin cream 5% — Prescribing Information (SPL effective 2026-07-24, version 3)↗[عمومی]
• FDA Prednisolone sol — Prednisolone sodium phosphate oral solution 25 mg/5 mL — Prescribing Information (SPL effective 2025-12-03, version 8)↗[عمومی]
• FDA Dexa Intensol — Dexamethasone Oral Solution USP Intensol (concentrate) 1 mg/mL — Prescribing Information (SPL effective 2026-08-21, version 1)↗[عمومی]
• FDA Delsym — DELSYM (dextromethorphan polistirex) extended-release suspension — Drug Facts (SPL effective 2026-09-09, version 15)↗[عمومی]
• FDA Children's Sudafed — Children's Sudafed Nasal Decongestant (pseudoephedrine HCl 15 mg/5 mL) — Drug Facts (SPL effective 2024-11-08, version 9)↗[عمومی]
• FDA Guaifenesin OTC — Max Tussin Mucus and Chest Congestion (guaifenesin 200 mg/10 mL) — Drug Facts (SPL effective 2026-08-31, version 5)↗[عمومی]
• FDA Omeprazole — Omeprazole delayed-release capsules — Prescribing Information (SPL effective 2026-09-01, version 1)↗[عمومی]
• FDA Protonix — PROTONIX (pantoprazole) delayed-release tablets and oral suspension — Prescribing Information (SPL effective 2026-05-18, version 48)↗[عمومی]
• FDA Metformin — Metformin hydrochloride tablets — Prescribing Information (SPL effective 2026-10-09, version 1)↗[عمومی]
• FDA Atorvastatin — Atorvastatin calcium tablets — Prescribing Information (SPL effective 2026-10-08, version 4)↗[عمومی]
• FDA Losartan — Losartan potassium tablets — Prescribing Information (SPL effective 2026-09-29, version 17)↗[عمومی]
• FDA Amlodipine — Amlodipine besylate tablets — Prescribing Information (SPL effective 2026-10-09, version 18)↗[عمومی]
• FDA Levothyroxine — Levothyroxine sodium tablets — Prescribing Information (SPL effective 2026-10-12, version 1)↗[عمومی]
• FDA Diclofenac DR — Diclofenac sodium delayed-release tablets — Prescribing Information (SPL effective 2026-09-24, version 1)↗[عمومی]
• FDA Ritalin — RITALIN (methylphenidate HCl) tablets — Prescribing Information (SPL effective 2025-02-05, version 3)↗[عمومی]
• FDA Sertraline — Sertraline hydrochloride tablets — Prescribing Information (SPL effective 2026-09-17, version 10)↗[عمومی]
• FDA Fluoxetine — Fluoxetine capsules — Prescribing Information (SPL effective 2026-10-02, version 1)↗[عمومی]
• FDA Celexa — CELEXA (citalopram) tablets — Prescribing Information (SPL effective 2023-10-09, version 40)↗[عمومی]
• FDA Aripiprazole — Aripiprazole tablets — Prescribing Information (SPL effective 2026-10-05, version 6)↗[عمومی]
• FDA Divalproex — Divalproex sodium delayed-release tablets — Prescribing Information (SPL effective 2026-10-07, version 1)↗[عمومی]
• FDA Lithium — Lithium carbonate tablets and capsules — Prescribing Information (SPL effective 2026-08-16, version 3)↗[عمومی]
• FDA Lexapro — LEXAPRO (escitalopram) tablets — Prescribing Information (SPL effective 2023-10-01, version 45)↗[عمومی]
• FDA Escitalopram — Escitalopram tablets — Prescribing Information (SPL effective 2026-10-09, version 1)↗[عمومی]
• FDA Quetiapine — Quetiapine tablets — Prescribing Information (SPL effective 2026-09-17, version 9)↗[عمومی]
• FDA Zyprexa — ZYPREXA (olanzapine) tablets — Prescribing Information (SPL effective 2026-10-06, version 69)↗[عمومی]
• FDA Clonazepam — Clonazepam tablets — Prescribing Information (SPL effective 2026-10-06, version 1)↗[عمومی]
• FDA Xanax — XANAX (alprazolam) tablets — Prescribing Information (SPL effective 2024-04-15, version 5)↗[عمومی]
• FDA Atomoxetine — Atomoxetine capsules — Prescribing Information (SPL effective 2026-09-29, version 9)↗[عمومی]
• FDA Carbamazepine — Carbamazepine tablets — Prescribing Information (SPL effective 2026-10-12, version 1)↗[عمومی]
• FDA Bupropion XL — Bupropion hydrochloride extended-release tablets (XL) — Prescribing Information (SPL effective 2026-07-16, version 42)↗[عمومی]
• FDA Venlafaxine XR — Venlafaxine hydrochloride extended-release capsules — Prescribing Information (SPL effective 2026-10-05, version 2)↗[عمومی]
• FDA Mirtazapine — Mirtazapine tablets — Prescribing Information (SPL effective 2026-10-06, version 13)↗[عمومی]
• FDA Trazodone — Trazodone hydrochloride tablets — Prescribing Information (SPL effective 2026-10-12, version 4)↗[عمومی]
• FDA Buspirone — Buspirone hydrochloride tablets — Prescribing Information (SPL effective 2026-10-10, version 1)↗[عمومی]
• FDA Haloperidol — Haloperidol tablets — Prescribing Information (SPL effective 2026-09-02, version 3)↗[عمومی]
• FDA Rizatriptan ODT — Rizatriptan benzoate orally disintegrating tablets — Prescribing Information (SPL effective 2026-10-09, version 14)↗[عمومی]
• FDA Sumatriptan — Sumatriptan tablets — Prescribing Information (SPL effective 2026-10-09, version 1)↗[عمومی]
• FDA Topiramate — Topiramate tablets — Prescribing Information (SPL effective 2026-10-13, version 17)↗[عمومی]
• FDA Propranolol — Propranolol hydrochloride tablets — Prescribing Information (SPL effective 2026-10-09, version 8)↗[عمومی]
• FDA Tobramycin eye — Tobramycin ophthalmic solution USP 0.3% — Prescribing Information (SPL effective 2024-06-14, version 1)↗[عمومی]
• FDA Cipro eye drops — Ciprofloxacin ophthalmic solution 0.3% — Prescribing Information (SPL effective 2026-05-05, version 2)↗[عمومی]
• FDA Erythromycin eye — Erythromycin ophthalmic ointment USP 0.5% — Prescribing Information (SPL effective 2026-08-28, version 12)↗[عمومی]
• FDA Pataday (OTC) — Pataday Twice Daily Relief (olopatadine 0.1%) — Drug Facts (SPL effective 2026-01-20, version 6)↗[عمومی]
• FDA Ketotifen eye (OTC) — Ketotifen fumarate ophthalmic solution 0.025% — Drug Facts (SPL effective 2026-04-15, version 1)↗[عمومی]
• FDA Enalapril — Enalapril maleate tablets USP — Prescribing Information (SPL effective 2026-09-16, version 3)↗[عمومی]
• FDA Captopril — Captopril tablets USP — Prescribing Information (SPL effective 2026-09-14, version 4)↗[عمومی]
• FDA Valsartan — Valsartan tablets USP — Prescribing Information (SPL effective 2026-08-25, version 23)↗[عمومی]
• FDA Metoprolol tartrate — Metoprolol tartrate tablets USP — Prescribing Information (SPL effective 2026-09-29, version 1)↗[عمومی]
• FDA Atenolol — Atenolol tablets USP — Prescribing Information (SPL effective 2026-09-28, version 13)↗[عمومی]
• FDA Carvedilol — Carvedilol tablets — Prescribing Information (SPL effective 2026-10-06, version 8)↗[عمومی]
• FDA Hydrochlorothiazide — Hydrochlorothiazide tablets USP — Prescribing Information (SPL effective 2026-10-12, version 5)↗[عمومی]
• FDA Furosemide tabs — Furosemide tablets USP — Prescribing Information (SPL effective 2026-06-18, version 4)↗[عمومی]
• FDA Furosemide solution — Furosemide oral solution USP 10 mg/mL — Prescribing Information (SPL effective 2026-06-23, version 1)↗[عمومی]
• FDA Spironolactone — Spironolactone tablets USP — Prescribing Information (SPL effective 2026-10-07, version 10)↗[عمومی]
• FDA Simvastatin — Simvastatin tablets USP — Prescribing Information (SPL effective 2026-08-31, version 4)↗[عمومی]
• FDA Rosuvastatin — Rosuvastatin calcium tablets — Prescribing Information (SPL effective 2026-10-06, version 9)↗[عمومی]
• FDA Crestor — Crestor (rosuvastatin) tablets — Prescribing Information (SPL effective 2026-09-23, version 19)↗[عمومی]
• FDA Clopidogrel — Clopidogrel tablets USP — Prescribing Information (SPL effective 2026-09-29, version 8)↗[عمومی]
• FDA Warfarin — Warfarin sodium tablets USP — Prescribing Information (SPL effective 2026-10-06, version 6)↗[عمومی]
• FDA Isosorbide dinitrate — Isosorbide dinitrate tablets USP — Prescribing Information (SPL effective 2026-07-31, version 18)↗[عمومی]
• FDA Digoxin — Digoxin tablets USP — Prescribing Information (SPL effective 2026-01-13, version 20)↗[عمومی]
• FDA Nitroglycerin SL — Nitroglycerin sublingual tablets USP — Prescribing Information (SPL effective 2026-09-03, version 5)↗[عمومی]
• FDA Aspirin 81 (OTC) — Aspirin 81 mg chewable tablets — Drug Facts (SPL effective 2026-10-06, version 2)↗[عمومی]
• FDA Glyburide — Glyburide (glibenclamide) tablets USP — Prescribing Information (SPL effective 2015-05-01, version 19)↗[عمومی]
• FDA Glimepiride — Glimepiride tablets USP — Prescribing Information (SPL effective 2026-09-24, version 1)↗[عمومی]
• FDA Glipizide — Glipizide tablets USP — Prescribing Information (SPL effective 2026-10-13, version 17)↗[عمومی]
• FDA Sitagliptin — Sitagliptin tablets — Prescribing Information (SPL effective 2026-09-16, version 3)↗[عمومی]
• FDA Jardiance — Jardiance (empagliflozin) tablets — Prescribing Information (SPL effective 2026-08-26, version 1)↗[عمومی]
• FDA Pioglitazone — Pioglitazone tablets USP — Prescribing Information (SPL effective 2025-03-05, version 1)↗[عمومی]
• FDA Pioglitazone (2) — Pioglitazone tablets — Prescribing Information (SPL effective 2026-09-15, version 2)↗[عمومی]
• FDA Methimazole — Methimazole tablets USP — Prescribing Information (SPL effective 2026-08-20, version 2)↗[عمومی]
• FDA Propylthiouracil — Propylthiouracil tablets USP — Prescribing Information (SPL effective 2026-08-25, version 18)↗[عمومی]
• FDA Humulin R — Humulin R (insulin human) U-100 injection — Prescribing Information (SPL effective 2026-06-16, version 35)↗[عمومی]
• FDA Macrobid — Macrobid (nitrofurantoin monohydrate/macrocrystals) capsules — Prescribing Information (SPL effective 2025-10-14, version 27)↗[عمومی]
• FDA Nitrofurantoin macro — Nitrofurantoin capsules USP (macrocrystals) — Prescribing Information (SPL effective 2026-04-23, version 5)↗[عمومی]
• FDA Nitrofurantoin susp — Nitrofurantoin oral suspension 25 mg/5 mL — Prescribing Information (SPL effective 2025-11-11, version 5)↗[عمومی]
• FDA Ciprofloxacin — Ciprofloxacin tablets USP — Prescribing Information (SPL effective 2026-10-08, version 5)↗[عمومی]
• FDA Levofloxacin — Levofloxacin tablets USP — Prescribing Information (SPL effective 2026-08-21, version 7)↗[عمومی]
• FDA Doxycycline — Doxycycline hyclate tablets USP — Prescribing Information (SPL effective 2026-10-06, version 2)↗[عمومی]
• FDA Ceftriaxone — Ceftriaxone for injection USP — Prescribing Information (SPL effective 2026-09-30, version 18)↗[عمومی]
• FDA Bicillin L-A — Bicillin L-A (penicillin G benzathine injectable suspension) — Prescribing Information (SPL effective 2026-07-21, version 35)↗[عمومی]
• FDA Diflucan — Diflucan (fluconazole) tablets and oral suspension — Prescribing Information (SPL effective 2026-04-02, version 57)↗[عمومی]
• FDA Terbinafine — Terbinafine tablets — Prescribing Information (SPL effective 2026-07-09, version 7)↗[عمومی]
• FDA Valacyclovir — Valacyclovir tablets USP — Prescribing Information (SPL effective 2026-09-10, version 3)↗[عمومی]
• FDA Valacyclovir 1 g — Valacyclovir hydrochloride tablets (500 mg, 1 g) — Prescribing Information (SPL effective 2026-08-13, version 6)↗[عمومی]
• FDA Cefdinir susp — Cefdinir for oral suspension USP — Prescribing Information (SPL effective 2026-10-09, version 1)↗[عمومی]
• FDA Naproxen — Naproxen tablets USP — Prescribing Information (SPL effective 2026-10-08, version 12)↗[عمومی]
• FDA Celecoxib — Celecoxib capsules — Prescribing Information (SPL effective 2025-04-01, version 22)↗[عمومی]
• FDA Meloxicam — Meloxicam tablets USP — Prescribing Information (SPL effective 2026-10-02, version 2)↗[عمومی]
• FDA Tramadol — Tramadol hydrochloride tablets USP — Prescribing Information (SPL effective 2026-10-12, version 5)↗[عمومی]
• FDA Methocarbamol — Methocarbamol tablets USP — Prescribing Information (SPL effective 2026-10-07, version 7)↗[عمومی]
• FDA Baclofen — Baclofen tablets USP — Prescribing Information (SPL effective 2026-08-24, version 24)↗[عمومی]
• FDA Baclofen (2) — Baclofen tablets USP 20 mg — Prescribing Information (SPL effective 2026-10-09, version 4)↗[عمومی]
• FDA Colcrys — Colcrys (colchicine) tablets — Prescribing Information (SPL effective 2022-10-01, version 4)↗[عمومی]
• FDA Allopurinol — Allopurinol tablets — Prescribing Information (SPL effective 2026-10-09, version 1)↗[عمومی]
• FDA Amitriptyline — Amitriptyline hydrochloride tablets USP — Prescribing Information (SPL effective 2026-09-08, version 10)↗[عمومی]
• FDA Nortriptyline — Nortriptyline hydrochloride capsules USP — Prescribing Information (SPL effective 2026-09-28, version 2)↗[عمومی]
• FDA Neurontin — Neurontin (gabapentin) capsules, tablets, oral solution — Prescribing Information (SPL effective 2026-05-12, version 48)↗[عمومی]
• FDA Gabapentin — Gabapentin capsules USP — Prescribing Information (SPL effective 2026-10-08, version 2)↗[عمومی]
• FDA Lyrica — Lyrica (pregabalin) capsules and oral solution — Prescribing Information (SPL effective 2025-04-15, version 18)↗[عمومی]
• FDA Pregabalin — Pregabalin capsules — Prescribing Information (SPL effective 2026-09-30, version 13)↗[عمومی]
• FDA Lamotrigine — Lamotrigine tablets / ODT — Prescribing Information (SPL effective 2026-09-24, version 8)↗[عمومی]
• FDA Levetiracetam tabs — Levetiracetam tablets USP — Prescribing Information (SPL effective 2026-09-11, version 1)↗[عمومی]
• FDA Levetiracetam sol — Levetiracetam oral solution 100 mg/mL — Prescribing Information (SPL effective 2026-09-22, version 27)↗[عمومی]
• FDA Phenytoin ER — Extended phenytoin sodium capsules USP — Prescribing Information (SPL effective 2026-08-20, version 2)↗[عمومی]
• FDA Phenytoin susp — Phenytoin oral suspension 125 mg/5 mL — Prescribing Information (SPL effective 2025-08-19, version 17)↗[عمومی]
• FDA Diazepam — Diazepam tablets USP — Prescribing Information (SPL effective 2023-04-04, version 17)↗[عمومی]
• FDA Lorazepam — Lorazepam tablets USP — Prescribing Information (SPL effective 2026-09-30, version 17)↗[عمومی]
• FDA Zolpidem — Zolpidem tartrate tablets — Prescribing Information (SPL effective 2026-09-01, version 27)↗[عمومی]
• FDA Promethazine — Promethazine hydrochloride tablets USP — Prescribing Information (SPL effective 2026-09-10, version 4)↗[عمومی]
• FDA Dimenhydrinate (OTC) — Dimenhydrinate 50 mg tablets — Drug Facts (SPL effective 2026-09-30, version 13)↗[عمومی]
• FDA Meclizine (OTC) — Meclizine HCl 25 mg tablets — Drug Facts (SPL effective 2026-10-05, version 2)↗[عمومی]
• FDA Loperamide (OTC) — Loperamide HCl 2 mg caplets — Drug Facts (SPL effective 2026-10-01, version 10)↗[عمومی]
• FDA Bisacodyl (OTC) — Bisacodyl 5 mg tablets — Drug Facts (SPL effective 2026-09-18, version 1)↗[عمومی]
• FDA Simethicone drops — Infants' gas relief drops (simethicone 20 mg/0.3 mL) — Drug Facts (SPL effective 2026-10-01, version 8)↗[عمومی]
• FDA Simethicone 125 — Simethicone 125 mg softgels — Drug Facts (SPL effective 2026-10-08, version 5)↗[عمومی]
• FDA Fluticasone nasal — Fluticasone propionate nasal spray USP 50 mcg — Prescribing Information (SPL effective 2026-09-24, version 12)↗[عمومی]
• FDA Atrovent HFA — Atrovent HFA (ipratropium bromide) inhalation aerosol — Prescribing Information (SPL effective 2025-11-05, version 21)↗[عمومی]
• FDA Tamsulosin — Tamsulosin hydrochloride capsules — Prescribing Information (SPL effective 2026-09-01, version 4)↗[عمومی]
• FDA Oxybutynin — Oxybutynin chloride tablets USP — Prescribing Information (SPL effective 2026-07-21, version 2)↗[عمومی]
• FDA Hydrocortisone 1% — Hydrocortisone 1% anti-itch cream — Drug Facts (SPL effective 2026-10-08, version 5)↗[عمومی]
• FDA Betamethasone val. — Betamethasone valerate ointment USP 0.1% — Prescribing Information (SPL effective 2026-03-19, version 5)↗[عمومی]
• FDA Mupirocin — Mupirocin ointment USP 2% — Prescribing Information (SPL effective 2026-08-20, version 4)↗[عمومی]
• FDA Ketoconazole cream — Ketoconazole cream 2% — Prescribing Information (SPL effective 2026-09-18, version 6)↗[عمومی]
• FDA Silver sulfadiazine — Silver sulfadiazine cream USP 1% — Prescribing Information (SPL effective 2026-07-13, version 10)↗[عمومی]
• FDA Medroxyprogesterone — Medroxyprogesterone acetate tablets USP — Prescribing Information (SPL effective 2026-09-25, version 7)↗[عمومی]
• FDA Lisinopril — Lisinopril tablets USP — Prescribing Information (SPL effective 2026-10-07, version 12)↗[عمومی]
• FDA Ramipril — Ramipril capsules USP — Prescribing Information (SPL effective 2026-09-18, version 19)↗[عمومی]
• FDA Irbesartan — Irbesartan tablets USP — Prescribing Information (SPL effective 2026-08-06, version 13)↗[عمومی]
• FDA Telmisartan — Telmisartan tablets USP — Prescribing Information (SPL effective 2026-05-29, version 3)↗[عمومی]
• FDA Bisoprolol — Bisoprolol fumarate tablets USP — Prescribing Information (SPL effective 2025-11-12, version 3)↗[عمومی]
• FDA Procardia XL — Procardia XL (nifedipine) extended-release tablets — Prescribing Information (SPL effective 2026-09-21, version 20)↗[عمومی]
• FDA Diltiazem — Diltiazem hydrochloride tablets USP — Prescribing Information (SPL effective 2025-05-05, version 1)↗[عمومی]
• FDA Hydralazine — Hydralazine hydrochloride tablets USP — Prescribing Information (SPL effective 2026-02-02, version 13)↗[عمومی]
• FDA Chlorthalidone — Chlorthalidone tablets USP — Prescribing Information (SPL effective 2026-09-21, version 2)↗[عمومی]
• FDA Ezetimibe — Ezetimibe tablets USP — Prescribing Information (SPL effective 2026-01-13, version 6)↗[عمومی]
• FDA Fenofibrate — Fenofibrate tablets 54/160 mg — Prescribing Information (SPL effective 2026-09-29, version 9)↗[عمومی]
• FDA Eliquis — Eliquis (apixaban) tablets — Prescribing Information (SPL effective 2025-04-17, version 30)↗[عمومی]
• FDA Xarelto — Xarelto (rivaroxaban) tablets — Prescribing Information (SPL effective 2026-09-10, version 65)↗[عمومی]
• FDA Farxiga — Farxiga (dapagliflozin) tablets — Prescribing Information (SPL effective 2026-06-03, version 49)↗[عمومی]
• FDA Alendronate — Alendronate sodium tablets USP — Prescribing Information (SPL effective 2026-06-12, version 17)↗[عمومی]
• FDA Lantus — Lantus (insulin glargine) injection — Prescribing Information (SPL effective 2025-06-02, version 35)↗[عمومی]
• FDA Penicillin VK — Penicillin V potassium tablets and oral solution — Prescribing Information (SPL effective 2023-01-31, version 15)↗[عمومی]
• FDA Cefadroxil caps — Cefadroxil capsules USP — Prescribing Information (SPL effective 2025-10-10, version 8)↗[عمومی]
• FDA Cefadroxil susp — Cefadroxil for oral suspension USP — Prescribing Information (SPL effective 2025-10-08, version 9)↗[عمومی]
• FDA Fosfomycin — Fosfomycin tromethamine granules for oral solution — Prescribing Information (SPL effective 2026-09-10, version 2)↗[عمومی]
• FDA Tinidazole — Tinidazole tablets — Prescribing Information (SPL effective 2025-12-17, version 9)↗[عمومی]
• FDA Griseofulvin susp — Griseofulvin oral suspension (microsize) — Prescribing Information (SPL effective 2023-09-30, version 17)↗[عمومی]
• FDA Itraconazole — Itraconazole capsules — Prescribing Information (SPL effective 2026-09-17, version 27)↗[عمومی]
• FDA Ivermectin — Ivermectin tablets USP 3 mg — Prescribing Information (SPL effective 2024-08-28, version 3)↗[عمومی]
• FDA Biltricide — Biltricide (praziquantel) tablets — Prescribing Information (SPL effective 2026-03-02, version 13)↗[عمومی]
• FDA Pyrantel (OTC) — Pinworm medicine (pyrantel pamoate) chewable tablets — Drug Facts (SPL effective 2026-07-27, version 1)↗[عمومی]
• FDA Famciclovir — Famciclovir tablets — Prescribing Information (SPL effective 2026-07-21, version 1)↗[عمومی]
• FDA Ofloxacin otic — Ofloxacin otic solution 0.3% — Prescribing Information (SPL effective 2026-09-15, version 10)↗[عمومی]
• FDA Nexium — Nexium (esomeprazole magnesium) delayed-release capsules — Prescribing Information (SPL effective 2025-12-19, version 74)↗[عمومی]
• FDA Lansoprazole — Lansoprazole delayed-release capsules — Prescribing Information (SPL effective 2022-03-01, version 26)↗[عمومی]
• FDA Pepto-Bismol (OTC) — Pepto-Bismol (bismuth subsalicylate 525 mg/30 mL) — Drug Facts (SPL effective 2026-10-06, version 19)↗[عمومی]
• FDA Senna (OTC) — Senna laxative (sennosides 8.6 mg) tablets — Drug Facts (SPL effective 2026-09-29, version 8)↗[عمومی]
• FDA Docusate (OTC) — Docusate sodium 100 mg softgels — Drug Facts (SPL effective 2026-10-07, version 2)↗[عمومی]
• FDA Metamucil (OTC) — Metamucil (psyllium husk) powder — Drug Facts (SPL effective 2026-10-02, version 22)↗[عمومی]
• FDA Prochlorperazine — Prochlorperazine maleate tablets — Prescribing Information (SPL effective 2026-10-05, version 2)↗[عمومی]
• FDA Advair Diskus — Advair Diskus (fluticasone propionate/salmeterol) — Prescribing Information (SPL effective 2026-03-26, version 32)↗[عمومی]
• FDA Spiriva Respimat — Spiriva Respimat (tiotropium) inhalation spray — Prescribing Information (SPL effective 2026-08-17, version 16)↗[عمومی]
• FDA QVAR RediHaler — QVAR RediHaler (beclomethasone dipropionate HFA) — Prescribing Information (SPL effective 2025-09-30, version 17)↗[عمومی]
• FDA Mometasone nasal — Mometasone furoate nasal spray 50 mcg (OTC) — Drug Facts (SPL effective 2026-03-06, version 5)↗[عمومی]
• FDA Azelastine nasal — Azelastine HCl nasal spray 205.5 mcg (OTC) — Drug Facts (SPL effective 2026-10-02, version 7)↗[عمومی]
• FDA Oxymetazoline (OTC) — Oxymetazoline HCl 0.05% nasal spray — Drug Facts (SPL effective 2026-10-01, version 4)↗[عمومی]
• FDA Benzonatate — Benzonatate capsules USP — Prescribing Information (SPL effective 2026-09-16, version 1)↗[عمومی]
• FDA Prednisone — Prednisone tablets USP — Prescribing Information (SPL effective 2026-09-15, version 10)↗[عمومی]
• FDA Medrol — Medrol (methylprednisolone) tablets — Prescribing Information (SPL effective 2025-11-14, version 25)↗[عمومی]
• FDA Paroxetine — Paroxetine tablets USP — Prescribing Information (SPL effective 2026-08-21, version 1)↗[عمومی]
• FDA Duloxetine — Duloxetine delayed-release capsules — Prescribing Information (SPL effective 2025-12-21, version 12)↗[عمومی]
• FDA Fluvoxamine — Fluvoxamine maleate tablets — Prescribing Information (SPL effective 2026-09-11, version 16)↗[عمومی]
• FDA Clomipramine — Clomipramine hydrochloride capsules USP — Prescribing Information (SPL effective 2025-12-26, version 10)↗[عمومی]
• FDA Imipramine — Imipramine hydrochloride tablets USP — Prescribing Information (SPL effective 2026-08-11, version 21)↗[عمومی]
• FDA Oxcarbazepine — Oxcarbazepine tablets — Prescribing Information (SPL effective 2026-08-26, version 1)↗[عمومی]
• FDA Cyclobenzaprine — Cyclobenzaprine hydrochloride tablets USP — Prescribing Information (SPL effective 2026-09-05, version 1)↗[عمومی]
• FDA Tizanidine — Tizanidine tablets — Prescribing Information (SPL effective 2026-09-18, version 15)↗[عمومی]
• FDA Ropinirole — Ropinirole tablets — Prescribing Information (SPL effective 2026-09-02, version 22)↗[عمومی]
• FDA Aricept — Aricept (donepezil hydrochloride) tablets — Prescribing Information (SPL effective 2021-12-30, version 33)↗[عمومی]
• FDA Memantine — Memantine hydrochloride tablets USP — Prescribing Information (SPL effective 2025-06-23, version 2)↗[عمومی]
• FDA Carbidopa-levodopa — Carbidopa and levodopa tablets USP — Prescribing Information (SPL effective 2026-07-09, version 21)↗[عمومی]
• FDA Varenicline — Varenicline tablets — Prescribing Information (SPL effective 2026-09-21, version 4)↗[عمومی]
• FDA Nicotine patch (OTC) — Nicotine transdermal system 21/14/7 mg — Drug Facts (SPL effective 2026-09-10, version 12)↗[عمومی]
• FDA Nicotine gum (OTC) — Nicotine polacrilex gum 2/4 mg — Drug Facts (SPL effective 2026-10-02, version 2)↗[عمومی]
• FDA Prazosin — Prazosin hydrochloride capsules USP — Prescribing Information (SPL effective 2026-10-08, version 5)↗[عمومی]
• FDA Clonidine — Clonidine hydrochloride tablets USP — Prescribing Information (SPL effective 2026-09-30, version 5)↗[عمومی]
• FDA Finasteride — Finasteride tablets 5 mg — Prescribing Information (SPL effective 2026-09-17, version 10)↗[عمومی]
• FDA Sildenafil — Sildenafil citrate tablets — Prescribing Information (SPL effective 2026-05-13, version 4)↗[عمومی]
• FDA Tadalafil — Tadalafil tablets — Prescribing Information (SPL effective 2025-03-01, version 9)↗[عمومی]
• FDA Solifenacin — Solifenacin succinate tablets — Prescribing Information (SPL effective 2026-09-22, version 2)↗[عمومی]
• FDA Tolterodine — Tolterodine tartrate tablets — Prescribing Information (SPL effective 2025-04-01, version 3)↗[عمومی]
• FDA Phenazopyridine — Phenazopyridine HCl 99.5 mg urinary pain relief — Drug Facts (SPL effective 2026-10-06, version 1)↗[عمومی]
• FDA Plan B One-Step — Plan B One-Step (levonorgestrel 1.5 mg) — Drug Facts (SPL effective 2023-01-31, version 5)↗[عمومی]
• FDA Norethindrone — Norethindrone acetate tablets USP 5 mg — Prescribing Information (SPL effective 2026-01-29, version 10)↗[عمومی]
• FDA Tranexamic acid — Tranexamic acid tablets 650 mg — Prescribing Information (SPL effective 2026-05-13, version 1)↗[عمومی]
• FDA MetroGel vaginal — Metronidazole vaginal gel 0.75% — Prescribing Information (SPL effective 2026-10-01, version 1)↗[عمومی]
• FDA Monistat 3 (OTC) — Monistat 3 (miconazole nitrate 200 mg) — Drug Facts (SPL effective 2026-09-24, version 4)↗[عمومی]
• FDA Clomiphene — Clomiphene citrate tablets USP 50 mg — Prescribing Information (SPL effective 2026-07-16, version 1)↗[عمومی]
• FDA Adapalene (OTC) — Adapalene 0.1% gel — Drug Facts (SPL effective 2026-09-22, version 4)↗[عمومی]
• FDA Benzoyl peroxide — Benzoyl peroxide 10% acne cream — Drug Facts (SPL effective 2026-10-08, version 3)↗[عمومی]
• FDA Clindamycin gel — Clindamycin phosphate gel USP 1% — Prescribing Information (SPL effective 2025-12-02, version 5)↗[عمومی]
• FDA Triamcinolone cream — Triamcinolone acetonide cream USP 0.1% — Prescribing Information (SPL effective 2026-07-07, version 4)↗[عمومی]
• FDA Clobetasol cream — Clobetasol propionate cream USP 0.05% — Prescribing Information (SPL effective 2023-12-29, version 12)↗[عمومی]
• FDA Nystatin cream — Nystatin cream USP 100,000 units/g — Prescribing Information (SPL effective 2026-05-01, version 9)↗[عمومی]
• FDA Acyclovir cream — Acyclovir cream 5% — Prescribing Information (SPL effective 2026-06-18, version 5)↗[عمومی]
• FDA EpiPen — EpiPen / EpiPen Jr (epinephrine) auto-injector — Prescribing Information (SPL effective 2023-02-15, version 37)↗[عمومی]
• FDA Carbamide peroxide — Carbamide peroxide 6.5% earwax removal drops — Drug Facts (SPL effective 2026-10-05, version 3)↗[عمومی]
• FDA Chlordiazepoxide — Chlordiazepoxide HCl capsules USP — Prescribing Information (SPL effective 2026-05-05, version 1)↗[عمومی]
• FDA Oxazepam — Oxazepam capsules USP — Prescribing Information (SPL effective 2025-09-22, version 1)↗[عمومی]
• FDA Trifluoperazine — Trifluoperazine HCl tablets USP — Prescribing Information (SPL effective 2025-07-22, version 11)↗[عمومی]
• FDA Perphenazine — Perphenazine tablets USP — Prescribing Information (SPL effective 2026-08-25, version 20)↗[عمومی]
• FDA Trihexyphenidyl — Trihexyphenidyl HCl tablets USP — Prescribing Information (SPL effective 2024-02-02, version 10)↗[عمومی]
• FDA Clozapine — Clozapine tablets USP — Prescribing Information (SPL effective 2026-05-11, version 1)↗[عمومی]
• FDA Geodon — Geodon (ziprasidone) capsules — Prescribing Information (SPL effective 2025-01-13, version 50)↗[عمومی]
• FDA Valproic acid sol. — Valproic acid oral solution 250 mg/5 mL — Prescribing Information (SPL effective 2025-01-24, version 22)↗[عمومی]
• FDA Cimetidine — Cimetidine tablets USP — Prescribing Information (SPL effective 2022-11-30, version 12)↗[عمومی]
• FDA Mylanta (OTC) — Mylanta (calcium carbonate / magnesium hydroxide / simethicone) — Drug Facts (SPL effective 2026-08-15, version 1)↗[عمومی]
• FDA Librax (generic) — Chlordiazepoxide HCl and clidinium bromide capsules — Prescribing Information (SPL effective 2025-09-03, version 5)↗[عمومی]
• FDA Mesalamine DR — Mesalamine delayed-release tablets 800 mg — Prescribing Information (SPL effective 2026-07-14, version 9)↗[عمومی]
• FDA Ursodiol — Ursodiol capsules USP 300 mg — Prescribing Information (SPL effective 2023-07-31, version 15)↗[عمومی]
• FDA APAP-codeine — Acetaminophen and codeine phosphate tablets USP — Prescribing Information (SPL effective 2026-09-18, version 10)↗[عمومی]
• FDA Albuterol syrup — Albuterol sulfate syrup 2 mg/5 mL — Prescribing Information (SPL effective 2025-12-17, version 1)↗[عمومی]
• FDA Albuterol neb — Albuterol sulfate inhalation solution 0.63/1.25 mg — Prescribing Information (SPL effective 2026-04-30, version 10)↗[عمومی]
• FDA Ampicillin — Ampicillin capsules USP — Prescribing Information (SPL effective 2025-08-14, version 4)↗[عمومی]
• FDA Dicloxacillin — Dicloxacillin sodium capsules USP — Prescribing Information (SPL effective 2022-06-22, version 12)↗[عمومی]
• FDA Gentamicin inj. — Gentamicin sulfate injection USP 40 mg/mL — Prescribing Information (SPL effective 2026-05-20, version 22)↗[عمومی]
• FDA FeverAll Jr (OTC) — FeverAll Jr. Strength (acetaminophen 325 mg) suppositories — Drug Facts (SPL effective 2026-09-03, version 8)↗[عمومی]
• FDA Fe-Vite drops — Fe-Vite iron oral solution (ferrous sulfate, 15 mg iron/mL) — supplement label (SPL effective 2026-04-10, version 6)↗[عمومی]
• FDA Diazepam rectal gel — Diazepam rectal gel 5 mg/mL — Prescribing Information (SPL effective 2026-05-28, version 3)↗[عمومی]
• FDA Ketorolac inj. — Ketorolac tromethamine injection — Prescribing Information (SPL effective 2026-09-29, version 3)↗[عمومی]
• FDA Metoclopramide inj. — Metoclopramide injection 5 mg/mL — Prescribing Information (SPL effective 2026-08-19, version 1)↗[عمومی]
• FDA Dexamethasone inj. — Dexamethasone sodium phosphate injection 4 mg/mL — Prescribing Information (SPL effective 2026-08-31, version 1)↗[عمومی]
• FDA Solu-Cortef — Solu-Cortef (hydrocortisone sodium succinate) — Prescribing Information (SPL effective 2026-09-29, version 31)↗[عمومی]
• FDA Promethazine inj. — Promethazine HCl injection 25 mg/mL — Prescribing Information (SPL effective 2025-12-18, version 3)↗[عمومی]
• FDA Diazepam inj. — Diazepam injection 5 mg/mL — Prescribing Information (SPL effective 2026-08-19, version 2)↗[عمومی]
• FDA Epinephrine 1 mg/mL — Epinephrine injection 1 mg/mL — Prescribing Information (SPL effective 2026-09-23, version 6)↗[عمومی]
• FDA Thiamine inj. — Thiamine hydrochloride injection 100 mg/mL — Prescribing Information (SPL effective 2026-10-06, version 2)↗[عمومی]
• FDA Levora — Levora 0.15/30 (levonorgestrel/ethinyl estradiol) — Prescribing Information (SPL effective 2025-07-24, version 10)↗[عمومی]
• FDA Crinone — Crinone (progesterone gel) 4%/8% — Prescribing Information (SPL effective 2024-05-21, version 11)↗[عمومی]
• FDA Cabergoline — Cabergoline tablets 0.5 mg — Prescribing Information (SPL effective 2026-06-22, version 4)↗[عمومی]
• FDA Bromocriptine — Bromocriptine mesylate tablets/capsules — Prescribing Information (SPL effective 2026-07-27, version 4)↗[عمومی]
• FDA Fluorometholone eye — Fluorometholone ophthalmic suspension 0.1% — Prescribing Information (SPL effective 2026-08-12, version 8)↗[عمومی]
• FDA Artificial tears — Artificial tears (dextran/glycerin/hypromellose) — Drug Facts (SPL effective 2026-07-07, version 5)↗[عمومی]
• FDA Ciprofloxacin otic — Ciprofloxacin otic solution 0.2% — Prescribing Information (SPL effective 2026-09-22, version 2)↗[عمومی]
• FDA Cipro HC otic — Ciprofloxacin/hydrocortisone otic suspension — Prescribing Information (SPL effective 2026-05-29, version 1)↗[عمومی]
• FDA Nizoral shampoo — Nizoral A-D (ketoconazole 1%) shampoo — Drug Facts (SPL effective 2026-09-10, version 8)↗[عمومی]
• FDA Rogaine women (OTC) — Women’s Rogaine (minoxidil 5% foam) — Drug Facts (SPL effective 2024-11-13, version 6)↗[عمومی]
• FDA Calamine lotion — Calamine lotion (calamine 8% / zinc oxide 8%) — Drug Facts (SPL effective 2026-01-29, version 3)↗[عمومی]
• FDA Urea 20% cream — Uracin (urea 20%) cream — product label (SPL effective 2026-10-06, version 6)↗[عمومی]
• FDA Atropine inj. — Atropine sulfate injection (Hospira) — Prescribing Information (SPL effective 2026-05-18, version 31)↗[عمومی]
• FDA Naloxone inj. — Naloxone hydrochloride injection (Dr. Reddy's) — Prescribing Information (SPL effective 2026-01-01, version 9)↗[عمومی]
• FDA Flumazenil inj. — Flumazenil injection 0.1 mg/mL — Prescribing Information (SPL effective 2025-12-18, version 2)↗[عمومی]
• FDA Gvoke (glucagon) — Gvoke (glucagon injection) — Prescribing Information (SPL effective 2026-10-06, version 22)↗[عمومی]
• FDA Dextrose 50% inj. — 50% Dextrose Injection, USP (25 g/50 mL syringe) — Prescribing Information (SPL effective 2024-02-22, version 5)↗[عمومی]
• FDA Mag. sulfate 50% — Magnesium sulfate injection 50% (Hospira) — Prescribing Information (SPL effective 2026-04-23, version 22)↗[عمومی]
• FDA Calcium gluconate — Calcium Gluconate in Sodium Chloride Injection — Prescribing Information (SPL effective 2026-07-31, version 4)↗[عمومی]
• FDA Actidose (charcoal) — Actidose activated charcoal suspension — Drug Facts (SPL effective 2026-07-28, version 8)↗[عمومی]
• FDA Xylocaine MPF — Xylocaine-MPF (lidocaine HCl) injection — Prescribing Information (SPL effective 2026-07-28, version 1)↗[عمومی]
• FDA Xylocaine Dental — 2% Xylocaine DENTAL (lidocaine HCl and epinephrine) — Prescribing Information (SPL effective 2026-08-13, version 10)↗[عمومی]
• FDA Diphenhydramine inj. — Diphenhydramine hydrochloride injection 50 mg/mL — Prescribing Information (SPL effective 2026-07-23, version 1)↗[عمومی]
• FDA Phytonadione inj. — Phytonadione injectable emulsion 1 mg/0.5 mL (Dr. Reddy's) — Prescribing Information (SPL effective 2026-09-30, version 8)↗[عمومی]
• FDA Morphine inj. — Morphine sulfate injection 4 mg/mL (Civica) — Prescribing Information (SPL effective 2026-09-01, version 5)↗[عمومی]
• FDA Meperidine inj. — Meperidine hydrochloride injection (Hikma) — Prescribing Information (SPL effective 2024-04-09, version 11)↗[عمومی]
• FDA Nayzilam — Nayzilam (midazolam) nasal spray 5 mg — Prescribing Information (SPL effective 2023-01-19, version 4)↗[عمومی]
• FDA Furosemide inj. — Furosemide injection 10 mg/mL (Amneal) — Prescribing Information (SPL effective 2026-09-17, version 15)↗[عمومی]
• FDA 0.9% NaCl (Baxter) — Sodium Chloride Injection, USP 0.9% (Viaflo) — Prescribing Information (SPL effective 2025-06-30, version 20)↗[عمومی]
• FDA Lactated Ringer's — Lactated Ringer's Injection, USP — Prescribing Information (SPL effective 2025-10-27, version 12)↗[عمومی]
• FDA Orabloc (articaine) — Orabloc (articaine HCl and epinephrine) dental injection — Prescribing Information (SPL effective 2026-09-22, version 3)↗[عمومی]
• FDA Polocaine Dental — Polocaine Dental (mepivacaine HCl 3%) — Prescribing Information (SPL effective 2024-02-21, version 1)↗[عمومی]
• FDA Anbesol Max — Anbesol Maximum Strength (benzocaine 20%) liquid — Drug Facts (SPL effective 2026-06-22, version 5)↗[عمومی]
• FDA Chlorhexidine rinse — Chlorhexidine gluconate 0.12% oral rinse — Prescribing Information (SPL effective 2026-09-22, version 1)↗[عمومی]
• FDA Advil Dual Action — Advil Dual Action with Acetaminophen (ibuprofen 125 mg / acetaminophen 250 mg) — Drug Facts (SPL effective 2026-07-04, version 1)↗[عمومی]
• FDA Advil tablets — Advil (ibuprofen 200 mg) tablets — Drug Facts (SPL effective 2026-07-03, version 2)↗[عمومی]
• FDA Aleve caplets — Aleve (naproxen sodium 220 mg) caplets — Drug Facts (SPL effective 2026-07-03, version 4)↗[عمومی]
• FDA Vardenafil — Vardenafil hydrochloride tablets (Lannett) — Prescribing Information (SPL effective 2026-07-15, version 9)↗[عمومی]
• FDA Stendra — Stendra (avanafil) tablets — Prescribing Information (SPL effective 2024-07-18, version 7)↗[عمومی]
• FDA Testosterone cyp. — Testosterone cypionate injection — Prescribing Information (SPL effective 2026-09-09, version 1)↗[عمومی]
• FDA AndroGel 1.62% — AndroGel (testosterone gel) 1.62% — Prescribing Information (SPL effective 2025-10-22, version 130)↗[عمومی]
• FDA Addyi — Addyi (flibanserin) tablets — Prescribing Information (SPL effective 2025-12-22, version 15)↗[عمومی]
• FDA Vyleesi — Vyleesi (bremelanotide) injection — Prescribing Information (SPL effective 2025-11-13, version 1)↗[عمومی]
• FDA Yasmin — Yasmin (drospirenone 3 mg / ethinyl estradiol 0.03 mg) — Prescribing Information (SPL effective 2023-05-19, version 21)↗[عمومی]
• FDA Depo-Provera CI — Depo-Provera CI (medroxyprogesterone acetate 150 mg/mL) — Prescribing Information (SPL effective 2026-08-25, version 29)↗[عمومی]
• FDA ella — ella (ulipristal acetate 30 mg) — Prescribing Information (SPL effective 2026-07-20, version 7)↗[عمومی]
• FDA Estrace cream — Estrace (estradiol vaginal cream 0.01%) — Prescribing Information (SPL effective 2024-05-29, version 25)↗[عمومی]
• FDA Verapamil ER — Verapamil hydrochloride extended-release tablets (Zydus) — Prescribing Information (SPL effective 2026-04-06, version 1)↗[عمومی]
• FDA Amiodarone tablets — Amiodarone hydrochloride tablets (Dr. Reddy's) — Prescribing Information (SPL effective 2026-04-23, version 2)↗[عمومی]
• FDA Enoxaparin — Enoxaparin sodium injection — Prescribing Information (SPL effective 2026-10-12, version 8)↗[عمومی]
• FDA Heparin inj. — Heparin sodium injection (Gland) — Prescribing Information (SPL effective 2026-09-09, version 13)↗[عمومی]
• FDA Dabigatran — Dabigatran etexilate capsules (Ascend) — Prescribing Information (SPL effective 2026-08-03, version 27)↗[عمومی]
• FDA Methyldopa — Methyldopa tablets (Rising) — Prescribing Information (SPL effective 2025-03-28, version 3)↗[عمومی]
• FDA Labetalol — Labetalol hydrochloride tablets — Prescribing Information (SPL effective 2026-06-08, version 4)↗[عمومی]
• FDA ISMN (Genus) — Isosorbide mononitrate tablets (Genus) — Prescribing Information (SPL effective 2026-04-09, version 1)↗[عمومی]
• FDA Candesartan — Candesartan cilexetil tablets — Prescribing Information (SPL effective 2026-09-07, version 4)↗[عمومی]
• FDA Perindopril — Perindopril erbumine tablets (Aurobindo) — Prescribing Information (SPL effective 2024-03-13, version 17)↗[عمومی]
• FDA Gemfibrozil — Gemfibrozil tablets 600 mg (Northstar) — Prescribing Information (SPL effective 2026-04-10, version 25)↗[عمومی]
• FDA Humulin N — Humulin N (human insulin isophane) — Prescribing Information (SPL effective 2025-12-19, version 50)↗[عمومی]
• FDA NovoLog — NovoLog (insulin aspart) — Prescribing Information (SPL effective 2023-02-28, version 34)↗[عمومی]
• FDA Tradjenta — Tradjenta (linagliptin) — Prescribing Information (SPL effective 2025-03-21, version 32)↗[عمومی]
• FDA Acarbose — Acarbose tablets (Strides) — Prescribing Information (SPL effective 2026-07-15, version 10)↗[عمومی]
• FDA Cortef tablets — Cortef (hydrocortisone) tablets — Prescribing Information (SPL effective 2025-02-17, version 17)↗[عمومی]
• FDA Fludrocortisone — Fludrocortisone acetate tablets 0.1 mg — Prescribing Information (SPL effective 2026-05-13, version 4)↗[عمومی]
• FDA Desmopressin tablets — Desmopressin acetate tablets (Apotex) — Prescribing Information (SPL effective 2026-09-10, version 10)↗[عمومی]
• FDA Calcitriol — Calcitriol capsules 0.25 mcg (Hikma) — Prescribing Information (SPL effective 2026-07-10, version 17)↗[عمومی]
• FDA Estradiol tablets — Estradiol tablets USP (Epic) — Prescribing Information (SPL effective 2026-02-26, version 13)↗[عمومی]
• FDA Premarin — Premarin (conjugated estrogens) tablets — Prescribing Information (SPL effective 2026-06-04, version 37)↗[عمومی]
• FDA Misoprostol — Misoprostol tablets (Mylan) — Prescribing Information (SPL effective 2026-08-25, version 16)↗[عمومی]
• FDA Methylergonovine — Methylergonovine maleate tablets 0.2 mg — Prescribing Information (SPL effective 2026-10-08, version 7)↗[عمومی]
• FDA Letrozole — Letrozole tablets 2.5 mg (Breckenridge) — Prescribing Information (SPL effective 2026-08-17, version 13)↗[عمومی]
• FDA Diclegis — Diclegis (doxylamine 10 mg / pyridoxine 10 mg) delayed-release — Prescribing Information (SPL effective 2025-12-03, version 15)↗[عمومی]
• FDA Cefazolin inj. — Cefazolin for injection (WG Critical Care) — Prescribing Information (SPL effective 2026-06-24, version 12)↗[عمومی]
• FDA Cefpodoxime susp. — Cefpodoxime proxetil for oral suspension (Rising) — Prescribing Information (SPL effective 2025-06-06, version 7)↗[عمومی]
• FDA Cefprozil susp. — Cefprozil for oral suspension (Northstar) — Prescribing Information (SPL effective 2026-07-09, version 9)↗[عمومی]
• FDA Cefaclor caps. — Cefaclor capsules (Carlsbad) — Prescribing Information (SPL effective 2025-05-01, version 4)↗[عمومی]
• FDA Tetracycline caps. — Tetracycline hydrochloride capsules (Breckenridge) — Prescribing Information (SPL effective 2026-05-22, version 9)↗[عمومی]
• FDA Minocycline caps. — Minocycline hydrochloride capsules (Actavis) — Prescribing Information (SPL effective 2025-06-01, version 24)↗[عمومی]
• FDA Moxifloxacin — Moxifloxacin hydrochloride tablets (Rising) — Prescribing Information (SPL effective 2025-10-10, version 12)↗[عمومی]
• FDA Rifampin caps. — Rifampin capsules (ANI) — Prescribing Information (SPL effective 2024-10-10, version 1)↗[عمومی]
• FDA Isoniazid — Isoniazid tablets (Marlex) — Prescribing Information (SPL effective 2025-09-11, version 3)↗[عمومی]
• FDA Hydroxychloroquine — Hydroxychloroquine sulfate tablets 200 mg (Teva) — Prescribing Information (SPL effective 2024-02-29, version 6)↗[عمومی]
• FDA Chloroquine — Chloroquine phosphate tablets (Amneal) — Prescribing Information (SPL effective 2026-09-29, version 12)↗[عمومی]
• FDA Primaquine — Primaquine phosphate tablets (Ingenus) — Prescribing Information (SPL effective 2026-02-23, version 5)↗[عمومی]
• FDA Cafergot — Cafergot (ergotamine tartrate 1 mg / caffeine 100 mg) tablets — Prescribing Information (SPL effective 2026-03-23, version 1)↗[عمومی]
• FDA Pramipexole — Pramipexole dihydrochloride tablets (Strides) — Prescribing Information (SPL effective 2025-08-17, version 12)↗[عمومی]
• FDA Amantadine caps. — Amantadine hydrochloride capsules 100 mg — Prescribing Information (SPL effective 2026-06-17, version 1)↗[عمومی]
• FDA Rivastigmine caps. — Rivastigmine tartrate capsules (Aurobindo) — Prescribing Information (SPL effective 2024-06-19, version 9)↗[عمومی]
• FDA Chlorpromazine — Chlorpromazine hydrochloride tablets (Northstar) — Prescribing Information (SPL effective 2026-08-26, version 7)↗[عمومی]
• FDA Doxepin caps. — Doxepin hydrochloride capsules (Amneal) — Prescribing Information (SPL effective 2026-08-20, version 16)↗[عمومی]
• FDA Xifaxan — Xifaxan (rifaximin) tablets — Prescribing Information (SPL effective 2025-06-25, version 50)↗[عمومی]
• FDA Creon — Creon (pancrelipase) delayed-release capsules — Prescribing Information (SPL effective 2024-02-28, version 109)↗[عمومی]
• FDA Glycerin suppository — Glycerin suppositories 2 g (CVS) — Drug Facts (SPL effective 2026-08-04, version 2)↗[عمومی]
• FDA NasalCrom — NasalCrom (cromolyn sodium 5.2 mg/spray) — Drug Facts (SPL effective 2026-06-03, version 14)↗[عمومی]
• FDA Symbicort — Symbicort (budesonide/formoterol) inhalation aerosol — Prescribing Information (SPL effective 2026-03-12, version 1)↗[عمومی]
• FDA Acetylcysteine sol. — Acetylcysteine solution 10%/20% (Hospira) — Prescribing Information (SPL effective 2026-05-22, version 22)↗[عمومی]
• FDA Zenatane — Zenatane (isotretinoin) capsules — Prescribing Information (SPL effective 2026-09-20, version 29)↗[عمومی]
• FDA Azelaic acid 15% — Azelaic acid gel 15% (Encube) — Prescribing Information (SPL effective 2025-12-24, version 3)↗[عمومی]
• FDA Tacrolimus oint. — Tacrolimus ointment 0.03%/0.1% (Glenmark) — Prescribing Information (SPL effective 2026-04-15, version 8)↗[عمومی]
• FDA Calcipotriene cream — Calcipotriene cream 0.005% (Glenmark) — Prescribing Information (SPL effective 2026-10-07, version 8)↗[عمومی]
• FDA Mometasone cream — Mometasone furoate cream 0.1% (Sun) — Prescribing Information (SPL effective 2025-07-07, version 6)↗[عمومی]
• FDA Desitin Max — Desitin Maximum Strength zinc oxide 40% paste — Drug Facts (SPL effective 2025-02-28, version 5)↗[عمومی]
• FDA Atropine 1% eye — Atropine sulfate ophthalmic solution 1% (Edenbridge) — Prescribing Information (SPL effective 2026-05-07, version 2)↗[عمومی]
• FDA Tropicamide — Tropicamide ophthalmic solution 0.5%/1% — Prescribing Information (SPL effective 2026-09-10, version 1)↗[عمومی]
• FDA Cyclogyl — Cyclogyl (cyclopentolate) ophthalmic solution — Prescribing Information (SPL effective 2024-06-25, version 15)↗[عمومی]
• FDA Timolol eye — Timolol maleate ophthalmic solution 0.25%/0.5% — Prescribing Information (SPL effective 2025-12-15, version 11)↗[عمومی]
• FDA Latanoprost — Latanoprost ophthalmic solution 0.005% — Prescribing Information (SPL effective 2026-09-08, version 4)↗[عمومی]
• FDA Pred acetate 1% eye — Prednisolone acetate ophthalmic suspension 1% — Prescribing Information (SPL effective 2026-07-23, version 1)↗[عمومی]
• FDA Tetracaine eye — Tetracaine hydrochloride ophthalmic solution 0.5% — Prescribing Information (SPL effective 2026-07-03, version 1)↗[عمومی]
• FDA Gentamicin eye — Gentamicin sulfate ophthalmic solution 0.3% (Bausch & Lomb) — Prescribing Information (SPL effective 2024-07-22, version 15)↗[عمومی]
• FDA Ofloxacin eye — Ofloxacin ophthalmic solution 0.3% (Apotex) — Prescribing Information (SPL effective 2026-09-15, version 13)↗[عمومی]
• FDA Sklice (OTC) — Sklice (ivermectin) lotion 0.5% — Drug Facts (SPL effective 2024-07-11, version 6)↗[عمومی]
• FDA Natroba — Natroba (spinosad 0.9%) topical suspension — Prescribing Information (SPL effective 2026-03-04, version 2)↗[عمومی]
• FDA Levocetirizine tab — Levocetirizine dihydrochloride tablets 5 mg (Glenmark) — Prescribing Information (SPL effective 2026-09-09, version 20)↗[عمومی]
• FDA Levocetirizine sol. — Levocetirizine dihydrochloride oral solution 2.5 mg/5 mL — Prescribing Information (SPL effective 2025-07-31, version 18)↗[عمومی]
• FDA Epinastine eye — Epinastine HCl ophthalmic solution 0.05% — Prescribing Information (SPL effective 2025-03-22, version 7)↗[عمومی]
• FDA Cromolyn 4% eye — Cromolyn sodium ophthalmic solution 4% (Sandoz) — Prescribing Information (SPL effective 2025-02-20, version 7)↗[عمومی]
• FDA Azelastine eye — Azelastine hydrochloride ophthalmic solution 0.05% (Apotex) — Prescribing Information (SPL effective 2026-09-08, version 11)↗[عمومی]
• FDA Naphazoline+phenir. — Naphazoline 0.02675% + pheniramine 0.315% eye drops (eye allergy relief) — Drug Facts (SPL effective 2026-09-28, version 4)↗[عمومی]
• FDA Terbutaline tab — Terbutaline sulfate tablets (Upsher-Smith) — Prescribing Information (SPL effective 2025-08-27, version 4)↗[عمومی]
• FDA Aminophylline inj. — Aminophylline injection 25 mg/mL (Hospira) — Prescribing Information (SPL effective 2026-05-22, version 29)↗[عمومی]
• FDA Rhinocort Aqua — Rhinocort Aqua (budesonide) nasal spray 32 mcg — Prescribing Information (SPL effective 2012-02-07, version 3)↗[عمومی]
• FDA Saline nasal 0.65% — Saline nasal spray (sodium chloride 0.65%) — Drug Facts (SPL effective 2026-10-02, version 1)↗[عمومی]
• FDA Claritin-D 12h — Claritin-D 12 Hour (loratadine 5 mg / pseudoephedrine sulfate 120 mg) — Drug Facts (SPL effective 2025-12-05, version 10)↗[عمومی]
• FDA Zyrtec-D — Zyrtec-D (cetirizine 5 mg / pseudoephedrine 120 mg) — Drug Facts (SPL effective 2026-04-06, version 6)↗[عمومی]
• FDA DayQuil liquid — Vicks DayQuil Cold & Flu (acetaminophen/dextromethorphan/phenylephrine) liquid — Drug Facts (SPL effective 2026-10-05, version 4)↗[عمومی]
• FDA NyQuil liquid — Vicks NyQuil Cold & Flu (acetaminophen/dextromethorphan/doxylamine) liquid — Drug Facts (SPL effective 2026-10-05, version 9)↗[عمومی]
• FDA Cetirizine 10mg tab — Cetirizine HCl 10 mg tablets (OTC) — Drug Facts (SPL effective 2026-10-08, version 6)↗[عمومی]
• FDA Loratadine 10mg tab — Loratadine 10 mg tablets (OTC) — Drug Facts (SPL effective 2026-10-07, version 6)↗[عمومی]
• FDA Hydroxyzine solution — Hydroxyzine HCl oral solution 10 mg/5 mL — Prescribing Information (SPL effective 2026-07-21, version 10)↗[عمومی]
• FDA Promethazine syrup — Promethazine HCl oral solution 6.25 mg/5 mL — Prescribing Information (SPL effective 2026-04-16, version 1)↗[عمومی]
• FDA Carbamazepine susp. — Carbamazepine tablets, chewable, XR and oral suspension 100 mg/5 mL (Sun) — Prescribing Information (SPL effective 2026-08-30, version 12)↗[عمومی]
• FDA Ondansetron sol. — Ondansetron oral solution 4 mg/5 mL — Prescribing Information (SPL effective 2026-03-31, version 2)↗[عمومی]
• FDA Cipro (tab+susp) — Cipro (ciprofloxacin) tablets and oral suspension (Bayer) — Prescribing Information (SPL effective 2026-03-02, version 32)↗[عمومی]
• FDA Claforan — Claforan (cefotaxime) for injection — Prescribing Information (SPL effective 2026-08-14, version 2)↗[عمومی]
• FDA Ceftazidime — Ceftazidime for injection (WG Critical Care) — Prescribing Information (SPL effective 2026-06-24, version 10)↗[عمومی]
• FDA Amikacin inj. — Amikacin sulfate injection 250 mg/mL (Sagent) — Prescribing Information (SPL effective 2026-07-27, version 10)↗[عمومی]
• FDA Vancomycin inj. — Vancomycin hydrochloride for injection (Glenmark) — Prescribing Information (SPL effective 2026-10-08, version 1)↗[عمومی]
• FDA Vancomycin caps — Vancomycin hydrochloride capsules (Cameron) — Prescribing Information (SPL effective 2026-08-17, version 6)↗[عمومی]
• FDA Penicillin G K inj. — Penicillin G potassium for injection (WG Critical Care) — Prescribing Information (SPL effective 2026-06-24, version 13)↗[عمومی]
• FDA Bicillin C-R — Bicillin C-R (penicillin G benzathine + procaine) — Prescribing Information (SPL effective 2026-07-21, version 29)↗[عمومی]
• FDA Ampicillin-sulbactam — Ampicillin and sulbactam for injection (Sagent) — Prescribing Information (SPL effective 2026-07-24, version 18)↗[عمومی]
• FDA Ethambutol — Ethambutol hydrochloride tablets (STI Pharma) — Prescribing Information (SPL effective 2026-05-05, version 9)↗[عمومی]
• FDA Pyrazinamide — Pyrazinamide tablets 500 mg (ANI) — Prescribing Information (SPL effective 2026-03-02, version 2)↗[عمومی]
• FDA Azithromycin inj. — Azithromycin for injection 500 mg (Sun) — Prescribing Information (SPL effective 2026-09-16, version 4)↗[عمومی]
• FDA Doxycycline susp. — Doxycycline for oral suspension 25 mg/5 mL (Lupin) — Prescribing Information (SPL effective 2025-10-23, version 21)↗[عمومی]
• FDA Cleocin Phosphate — Cleocin Phosphate (clindamycin injection 150 mg/mL) — Prescribing Information (SPL effective 2026-07-29, version 60)↗[عمومی]
• FDA Clindamycin caps — Clindamycin hydrochloride capsules (Aurobindo) — Prescribing Information (SPL effective 2026-09-21, version 23)↗[عمومی]
• FDA Metronidazole inj. — Metronidazole injection 500 mg/100 mL (WG Critical Care) — Prescribing Information (SPL effective 2026-10-06, version 4)↗[عمومی]
• FDA Ampicillin inj. — Ampicillin for injection (Sagent) — Prescribing Information (SPL effective 2026-07-27, version 2)↗[عمومی]
• FDA Cephalexin caps — Cephalexin capsules (Aurobindo) — Prescribing Information (SPL effective 2026-09-15, version 19)↗[عمومی]
• FDA Erythromycin tabs — Erythromycin tablets 250/500 mg (Torrent) — Prescribing Information (SPL effective 2026-03-05, version 11)↗[عمومی]
• FDA Neosporin — Neosporin Original (bacitracin/neomycin/polymyxin B) ointment — Drug Facts (SPL effective 2025-02-21, version 3)↗[عمومی]
• FDA Coartem — Coartem (artemether/lumefantrine) tablets — Prescribing Information (SPL effective 2026-03-26, version 25)↗[عمومی]
• FDA Malarone — Malarone (atovaquone/proguanil) tablets — Prescribing Information (SPL effective 2026-06-10, version 31)↗[عمومی]
• FDA Mefloquine — Mefloquine hydrochloride tablets (Teva) — Prescribing Information (SPL effective 2025-09-26, version 13)↗[عمومی]
• FDA Quinine sulfate — Quinine sulfate capsules 324 mg (Lupin) — Prescribing Information (SPL effective 2025-10-31, version 14)↗[عمومی]
• FDA Egaten — Egaten (triclabendazole) tablets — Prescribing Information (SPL effective 2026-06-04, version 12)↗[عمومی]
• FDA Humatin — Humatin (paromomycin) capsules — Prescribing Information (SPL effective 2025-11-13, version 3)↗[عمومی]
• FDA Impavido — Impavido (miltefosine) capsules — Prescribing Information (SPL effective 2026-10-08, version 15)↗[عمومی]
• FDA Ovide — Ovide (malathion) lotion 0.5% — Prescribing Information (SPL effective 2026-07-15, version 3)↗[عمومی]
• FDA Eurax — Eurax (crotamiton) cream 10% — Prescribing Information (SPL effective 2025-12-17, version 2)↗[عمومی]
• FDA Lamisil AT cream — Lamisil AT (terbinafine 1%) cream — Drug Facts (SPL effective 2025-11-18, version 6)↗[عمومی]
• FDA Econazole cream — Econazole nitrate cream 1% (Encube) — Prescribing Information (SPL effective 2026-06-22, version 1)↗[عمومی]
• FDA Clotrimazole troche — Clotrimazole lozenges 10 mg (Rising) — Prescribing Information (SPL effective 2025-03-27, version 2)↗[عمومی]
• FDA Vfend IV — Vfend I.V. (voriconazole) for injection — Prescribing Information (SPL effective 2026-03-20, version 33)↗[عمومی]
• FDA AmBisome — AmBisome (amphotericin B liposome) for injection — Prescribing Information (SPL effective 2026-10-02, version 14)↗[عمومی]
• FDA Acyclovir tablets — Acyclovir tablets 400/800 mg (Avet) — Prescribing Information (SPL effective 2026-07-24, version 6)↗[عمومی]
• FDA Acyclovir capsules — Acyclovir capsules 200 mg (Avet) — Prescribing Information (SPL effective 2026-07-08, version 8)↗[عمومی]
• FDA Acyclovir injection — Acyclovir sodium injection 50 mg/mL (AuroMedics) — Prescribing Information (SPL effective 2017-09-18, version 2)↗[عمومی]
• FDA Viread — Viread (tenofovir disoproxil fumarate) — Prescribing Information (SPL effective 2025-02-18, version 31)↗[عمومی]
• FDA Baraclude — Baraclude (entecavir) tablets and oral solution — Prescribing Information (SPL effective 2019-11-06, version 42)↗[عمومی]
• FDA Epclusa — Epclusa (sofosbuvir/velpatasvir) — Prescribing Information (SPL effective 2024-06-05, version 14)↗[عمومی]
• FDA Truvada — Truvada (emtricitabine/tenofovir DF) — Prescribing Information (SPL effective 2025-07-16, version 32)↗[عمومی]
• FDA Paxlovid — Paxlovid (nirmatrelvir; ritonavir) — Prescribing Information (SPL effective 2026-02-19, version 12)↗[عمومی]
• FDA Xofluza — Xofluza (baloxavir marboxil) — Prescribing Information (SPL effective 2025-12-15, version 30)↗[عمومی]
• FDA Adenosine inj. — Adenosine injection 3 mg/mL (Sagent) — Prescribing Information (SPL effective 2026-07-27, version 2)↗[عمومی]
• FDA Cerebyx — Cerebyx (fosphenytoin sodium) injection — Prescribing Information (SPL effective 2025-08-28, version 38)↗[عمومی]
• FDA Amiodarone inj. — Amiodarone hydrochloride injection 50 mg/mL — Prescribing Information (SPL effective 2026-01-16, version 6)↗[عمومی]
• FDA Lorazepam inj. — Lorazepam injection 2 and 4 mg/mL (Hospira) — Prescribing Information (SPL effective 2026-07-10, version 28)↗[عمومی]
• FDA Levetiracetam IV — Levetiracetam in sodium chloride injection (WG Critical Care) — Prescribing Information (SPL effective 2024-03-29, version 7)↗[عمومی]
• FDA Ondansetron inj. — Ondansetron injection 2 mg/mL (Civica) — Prescribing Information (SPL effective 2026-04-19, version 4)↗[عمومی]
• FDA Protopam — Protopam (pralidoxime chloride) for injection — Prescribing Information (SPL effective 2026-04-01, version 15)↗[عمومی]
• FDA Deferoxamine — Deferoxamine mesylate for injection (Fresenius Kabi) — Prescribing Information (SPL effective 2026-06-15, version 9)↗[عمومی]
• FDA Fomepizole — Fomepizole injection 1 g/mL (Zydus) — Prescribing Information (SPL effective 2025-11-20, version 8)↗[عمومی]
• FDA ProvayBlue — ProvayBlue (methylene blue) injection 0.5% — Prescribing Information (SPL effective 2025-05-28, version 28)↗[عمومی]
• FDA Protamine — Protamine sulfate injection 10 mg/mL (Fresenius Kabi) — Prescribing Information (SPL effective 2025-04-29, version 1)↗[عمومی]
• FDA DigiFab — DigiFab (digoxin immune fab, ovine) — Prescribing Information (SPL effective 2026-09-29, version 11)↗[عمومی]
• FDA Cyanokit — Cyanokit (hydroxocobalamin) 5 g for injection — Prescribing Information (SPL effective 2023-04-27, version 2)↗[عمومی]
• FDA HyperTET — HyperTET (tetanus immune globulin, human) 250 units — Prescribing Information (SPL effective 2024-09-20, version 20)↗[عمومی]
• FDA HyperRAB — HyperRAB (rabies immune globulin, human) 300 IU/mL — Prescribing Information (SPL effective 2024-09-20, version 10)↗[عمومی]
• FDA HyperHEP B — HyperHEP B (hepatitis B immune globulin, human) — Prescribing Information (SPL effective 2024-09-20, version 26)↗[عمومی]
• FDA Boostrix — Boostrix (Tdap vaccine) — Prescribing Information (SPL effective 2026-07-17, version 45)↗[عمومی]
• FDA Imovax Rabies — Imovax Rabies (rabies vaccine) — Prescribing Information (SPL effective 2026-02-02, version 24)↗[عمومی]
• FDA Engerix-B — Engerix-B (hepatitis B vaccine) — Prescribing Information (SPL effective 2026-05-14, version 35)↗[عمومی]
• FDA Fluzone — Fluzone (influenza vaccine) 2026–2027 — Prescribing Information (SPL effective 2026-06-29, version 13)↗[عمومی]
• FDA M-M-R II — M-M-R II (measles, mumps, rubella vaccine live) — Prescribing Information (SPL effective 2025-11-07, version 43)↗[عمومی]
• FDA Varivax — Varivax (varicella vaccine live) — Prescribing Information (SPL effective 2026-08-06, version 48)↗[عمومی]
• FDA Gardasil 9 — Gardasil 9 (HPV 9-valent vaccine) — Prescribing Information (SPL effective 2026-07-13, version 31)↗[عمومی]
• FDA Prevnar 20 — Prevnar 20 (pneumococcal 20-valent conjugate vaccine) — Prescribing Information (SPL effective 2026-07-24, version 12)↗[عمومی]
• FDA Havrix — Havrix (hepatitis A vaccine) — Prescribing Information (SPL effective 2026-05-14, version 33)↗[عمومی]
• FDA Pitocin — Pitocin (oxytocin injection) — Prescribing Information (SPL effective 2026-05-05, version 15)↗[عمومی]
• FDA Carboprost — Carboprost tromethamine injection 250 mcg/mL — Prescribing Information (SPL effective 2026-08-14, version 1)↗[عمومی]
• FDA RhoGAM — RhoGAM Ultra-Filtered PLUS (Rho(D) immune globulin) — Prescribing Information (SPL effective 2025-07-24, version 19)↗[عمومی]
• FDA Zurzuvae — Zurzuvae (zuranolone) capsules — Prescribing Information (SPL effective 2026-06-15, version 18)↗[عمومی]
• FDA Methylergonovine inj — Methylergonovine maleate injection 0.2 mg/mL (American Regent) — Prescribing Information (SPL effective 2026-03-04, version 8)↗[عمومی]
• FDA Prometrium — Prometrium (progesterone) capsules — Prescribing Information (SPL effective 2026-07-23, version 4)↗[عمومی]
• FDA Veozah — Veozah (fezolinetant) tablets — Prescribing Information (SPL effective 2026-02-26, version 8)↗[عمومی]
• FDA Clindesse — Clindesse (clindamycin phosphate) vaginal cream 2% — Prescribing Information (SPL effective 2025-01-30, version 12)↗[عمومی]
• FDA Terconazole cream — Terconazole vaginal cream 0.4% (Fougera) — Prescribing Information (SPL effective 2026-01-28, version 11)↗[عمومی]
• FDA Orilissa — Orilissa (elagolix) tablets — Prescribing Information (SPL effective 2025-12-19, version 112)↗[عمومی]
• FDA Caffeine cit. oral — Caffeine citrate oral solution 20 mg/mL (Armas) — Prescribing Information (SPL effective 2023-07-31, version 2)↗[عمومی]
• FDA Caffeine cit. inj. — Caffeine citrate injection 20 mg/mL (Eugia) — Prescribing Information (SPL effective 2025-04-19, version 6)↗[عمومی]
• FDA Curosurf — Curosurf (poractant alfa) intratracheal suspension — Prescribing Information (SPL effective 2025-12-10, version 45)↗[عمومی]
• FDA NeoProfen — NeoProfen (ibuprofen lysine) injection — Prescribing Information (SPL effective 2024-10-15, version 17)↗[عمومی]
• FDA Sezaby — Sezaby (phenobarbital sodium) for injection — Prescribing Information (SPL effective 2025-12-23, version 7)↗[عمومی]
• FDA Beyfortus — Beyfortus (nirsevimab-alip) injection — Prescribing Information (SPL effective 2026-07-13, version 32)↗[عمومی]
• FDA Entresto — Entresto (sacubitril/valsartan) — Prescribing Information (SPL effective 2026-07-06, version 25)↗[عمومی]
• FDA Corlanor — Corlanor (ivabradine) — Prescribing Information (SPL effective 2025-11-10, version 33)↗[عمومی]
• FDA Bumetanide — Bumetanide tablets (Northstar) — Prescribing Information (SPL effective 2026-08-21, version 4)↗[عمومی]
• FDA Torsemide — Torsemide tablets (AvKARE) — Prescribing Information (SPL effective 2026-02-11, version 9)↗[عمومی]
• FDA Eplerenone — Eplerenone tablets (Breckenridge) — Prescribing Information (SPL effective 2026-03-17, version 8)↗[عمومی]
• FDA Olmesartan — Olmesartan medoxomil tablets (Umedica) — Prescribing Information (SPL effective 2026-09-30, version 4)↗[عمومی]
• FDA Nebivolol — Nebivolol tablets (Solco) — Prescribing Information (SPL effective 2026-01-31, version 5)↗[عمومی]
• FDA Brilinta — Brilinta (ticagrelor) tablets — Prescribing Information (SPL effective 2026-05-07, version 56)↗[عمومی]
• FDA Ranolazine ER — Ranolazine extended-release tablets (Zydus) — Prescribing Information (SPL effective 2026-09-18, version 5)↗[عمومی]
• FDA Cilostazol — Cilostazol tablets (Apotex) — Prescribing Information (SPL effective 2026-09-10, version 11)↗[عمومی]
• FDA Pentoxifylline ER — Pentoxifylline extended-release tablets 400 mg — Prescribing Information (SPL effective 2026-09-11, version 1)↗[عمومی]
• FDA Labetalol inj. — Labetalol hydrochloride injection 5 mg/mL (Hospira) — Prescribing Information (SPL effective 2026-09-14, version 30)↗[عمومی]
• FDA Hydralazine inj. — Hydralazine hydrochloride injection 20 mg/mL (Zydus) — Prescribing Information (SPL effective 2026-05-06, version 2)↗[عمومی]
• FDA Ozempic — Ozempic (semaglutide) injection — Prescribing Information (SPL effective 2026-06-01, version 20)↗[عمومی]
• FDA Victoza — Victoza (liraglutide) injection — Prescribing Information (SPL effective 2025-10-14, version 31)↗[عمومی]
• FDA Mounjaro — Mounjaro (tirzepatide) injection — Prescribing Information (SPL effective 2026-08-27, version 40)↗[عمومی]
• FDA Repaglinide — Repaglinide tablets (Northstar) — Prescribing Information (SPL effective 2025-09-15, version 2)↗[عمومی]
• FDA Venofer — Venofer (iron sucrose) injection — Prescribing Information (SPL effective 2026-03-01, version 45)↗[عمومی]
• FDA Injectafer — Injectafer (ferric carboxymaltose) injection — Prescribing Information (SPL effective 2026-08-19, version 30)↗[عمومی]
• FDA Epogen — Epogen (epoetin alfa) — Prescribing Information (SPL effective 2026-06-23, version 137)↗[عمومی]
• FDA Jadenu — Jadenu (deferasirox) tablets and granules — Prescribing Information (SPL effective 2025-12-11, version 26)↗[عمومی]
• FDA Siklos — Siklos (hydroxyurea) tablets — Prescribing Information (SPL effective 2026-01-07, version 13)↗[عمومی]
• FDA Renvela — Renvela (sevelamer carbonate) — Prescribing Information (SPL effective 2025-11-25, version 47)↗[عمومی]
• FDA Calcium acetate — Calcium acetate capsules 667 mg (Rising) — Prescribing Information (SPL effective 2026-05-15, version 6)↗[عمومی]
• FDA SPS suspension — Sodium polystyrene sulfonate suspension 15 g/60 mL (Burel) — Prescribing Information (SPL effective 2025-05-01, version 2)↗[عمومی]
• FDA Lokelma — Lokelma (sodium zirconium cyclosilicate) — Prescribing Information (SPL effective 2024-02-08, version 28)↗[عمومی]
• FDA Sensipar — Sensipar (cinacalcet) tablets — Prescribing Information (SPL effective 2025-12-07, version 136)↗[عمومی]
• FDA Oxycodone IR — Oxycodone hydrochloride tablets (SpecGx) — Prescribing Information (SPL effective 2026-08-07, version 36)↗[عمومی]
• FDA Morphine IR tab — Morphine sulfate tablets 15/30 mg (SpecGx) — Prescribing Information (SPL effective 2026-07-30, version 10)↗[عمومی]
• FDA Indomethacin — Indomethacin capsules (Glenmark) — Prescribing Information (SPL effective 2025-12-19, version 13)↗[عمومی]
• FDA Piroxicam — Piroxicam capsules (Teva) — Prescribing Information (SPL effective 2026-08-19, version 21)↗[عمومی]
• FDA Voltaren gel — Voltaren Arthritis Pain (diclofenac sodium 1%) gel — Drug Facts (SPL effective 2025-02-11, version 13)↗[عمومی]
• FDA Lidoderm — Lidoderm (lidocaine patch 5%) — Prescribing Information (SPL effective 2022-12-02, version 3)↗[عمومی]
• FDA Methotrexate tab — Methotrexate tablets 2.5 mg (Alembic) — Prescribing Information (SPL effective 2026-05-18, version 6)↗[عمومی]
• FDA Sulfasalazine DR — Sulfasalazine delayed-release tablets (Mylan) — Prescribing Information (SPL effective 2026-08-25, version 31)↗[عمومی]
• FDA Leflunomide — Leflunomide tablets (Burel) — Prescribing Information (SPL effective 2026-05-01, version 10)↗[عمومی]
• FDA Febuxostat — Febuxostat tablets (HEC) — Prescribing Information (SPL effective 2026-03-10, version 1)↗[عمومی]
• FDA Risedronate DR — Risedronate sodium delayed-release tablets 35 mg (Mylan) — Prescribing Information (SPL effective 2026-02-03, version 7)↗[عمومی]
• FDA Reclast — Reclast (zoledronic acid) 5 mg/100 mL injection — Prescribing Information (SPL effective 2026-02-03, version 3)↗[عمومی]
• FDA Prolia — Prolia (denosumab) injection — Prescribing Information (SPL effective 2026-06-26, version 186)↗[عمومی]
• FDA Raloxifene — Raloxifene hydrochloride tablets (Teva) — Prescribing Information (SPL effective 2021-08-01, version 12)↗[عمومی]
• FDA Carafate — Carafate (sucralfate) 1 g tablets — Prescribing Information (SPL effective 2024-05-21, version 18)↗[عمومی]
• FDA Motegrity — Motegrity (prucalopride) tablets — Prescribing Information (SPL effective 2025-07-17, version 12)↗[عمومی]
• FDA Linzess — Linzess (linaclotide) capsules — Prescribing Information (SPL effective 2026-05-21, version 39)↗[عمومی]
• FDA Budesonide EC — Budesonide delayed-release capsules 3 mg (Padagis) — Prescribing Information (SPL effective 2024-06-05, version 10)↗[عمومی]
• FDA Azathioprine — Azathioprine tablets 50 mg (Glenmark) — Prescribing Information (SPL effective 2026-09-21, version 37)↗[عمومی]
• FDA Voquezna — Voquezna (vonoprazan) tablets — Prescribing Information (SPL effective 2026-07-16, version 6)↗[عمومی]
• FDA Retin-A Micro — Retin-A Micro (tretinoin) gel — Prescribing Information (SPL effective 2025-09-01, version 23)↗[عمومی]
• FDA Tri-Luma — Tri-Luma (fluocinolone/hydroquinone/tretinoin) cream — Prescribing Information (SPL effective 2024-10-24, version 18)↗[عمومی]
• FDA Soolantra — Soolantra (ivermectin) cream 1% — Prescribing Information (SPL effective 2024-10-24, version 8)↗[عمومی]
• FDA Pimecrolimus — Pimecrolimus cream 1% (Oceanside) — Prescribing Information (SPL effective 2026-04-30, version 4)↗[عمومی]
• FDA Desonide cream — Desonide cream 0.05% (Alembic) — Prescribing Information (SPL effective 2026-02-03, version 6)↗[عمومی]
• FDA Imiquimod 3.75% — Imiquimod cream 3.75% — Prescribing Information (SPL effective 2026-09-22, version 1)↗[عمومی]
• FDA Condylox — Condylox (podofilox) gel 0.5% — Prescribing Information (SPL effective 2024-01-29, version 8)↗[عمومی]
• FDA Buprenorphine-nalox. — Buprenorphine and naloxone sublingual tablets (Hikma) — Prescribing Information (SPL effective 2026-07-26, version 32)↗[عمومی]
• FDA Methadone 40 mg — Methadone hydrochloride tablets for oral suspension 40 mg (VistaPharm) — Prescribing Information (SPL effective 2026-02-09, version 22)↗[عمومی]
• FDA Naltrexone — Naltrexone hydrochloride tablets 50 mg (SpecGx) — Prescribing Information (SPL effective 2026-09-04, version 15)↗[عمومی]
• FDA Acamprosate DR — Acamprosate calcium delayed-release tablets 333 mg (Somerset) — Prescribing Information (SPL effective 2026-07-14, version 1)↗[عمومی]
• FDA Disulfiram — Disulfiram tablets 250 mg (Alvogen) — Prescribing Information (SPL effective 2025-10-07, version 14)↗[عمومی]
• FDA Vyvanse — Vyvanse (lisdexamfetamine) — Prescribing Information (SPL effective 2026-04-30, version 81)↗[عمومی]
• FDA Guanfacine ER — Guanfacine extended-release tablets (Upsher-Smith) — Prescribing Information (SPL effective 2026-09-30, version 16)↗[عمومی]
• FDA Trintellix — Trintellix (vortioxetine) tablets — Prescribing Information (SPL effective 2025-03-05, version 18)↗[عمومی]
• FDA Pyridostigmine — Pyridostigmine bromide tablets (Method) — Prescribing Information (SPL effective 2026-02-12, version 2)↗[عمومی]
• FDA Rasagiline — Rasagiline tablets (Alvogen) — Prescribing Information (SPL effective 2026-10-06, version 8)↗[عمومی]
• FDA Vimpat — Vimpat (lacosamide) tablets, injection and oral solution — Prescribing Information (SPL effective 2026-05-12, version 63)↗[عمومی]
• FDA Ethosuximide soln — Ethosuximide oral solution 250 mg/5 mL (Mylan) — Prescribing Information (SPL effective 2026-07-24, version 17)↗[عمومی]
• FDA Onfi — Onfi (clobazam) tablets and oral suspension — Prescribing Information (SPL effective 2024-03-12, version 42)↗[عمومی]
• FDA Nurtec ODT — Nurtec ODT (rimegepant) — Prescribing Information (SPL effective 2026-06-04, version 32)↗[عمومی]
• FDA Vigamox — Vigamox (moxifloxacin 0.5%) ophthalmic solution — Prescribing Information (SPL effective 2026-01-22, version 4)↗[عمومی]
• FDA Brimonidine 0.1% — Brimonidine tartrate ophthalmic solution 0.1% (Lifestar) — Prescribing Information (SPL effective 2026-09-03, version 6)↗[عمومی]
• FDA Dorzolamide/timolol — Dorzolamide hydrochloride and timolol maleate ophthalmic solution (Aurobindo) — Prescribing Information (SPL effective 2026-08-13, version 7)↗[عمومی]
• FDA Acetazolamide — Acetazolamide tablets (Ajanta) — Prescribing Information (SPL effective 2026-01-20, version 7)↗[عمومی]
• FDA Restasis — Restasis MultiDose (cyclosporine 0.05%) ophthalmic emulsion — Prescribing Information (SPL effective 2025-08-21, version 15)↗[عمومی]
• FDA TobraDex ST — TobraDex ST (tobramycin/dexamethasone) ophthalmic suspension — Prescribing Information (SPL effective 2025-04-01, version 3)↗[عمومی]
• FDA Acular — Acular (ketorolac 0.5%) ophthalmic solution — Prescribing Information (SPL effective 2025-09-18, version 16)↗[عمومی]
• FDA Norepinephrine bag — Norepinephrine bitartrate in sodium chloride injection (WG Critical Care) — Prescribing Information (SPL effective 2026-04-01, version 11)↗[عمومی]
• FDA Dopamine premix — Dopamine hydrochloride and 5% dextrose injection (Baxter) — Prescribing Information (SPL effective 2020-11-11, version 18)↗[عمومی]
• FDA Dobutamine — Dobutamine injection 12.5 mg/mL (Hospira) — Prescribing Information (SPL effective 2026-05-27, version 19)↗[عمومی]
• FDA Vasostrict — Vasostrict (vasopressin) injection — Prescribing Information (SPL effective 2026-04-21, version 49)↗[عمومی]
• FDA Brevibloc — Brevibloc (esmolol) injection — Prescribing Information (SPL effective 2025-03-14, version 15)↗[عمومی]
• FDA Activase — Activase (alteplase) for injection — Prescribing Information (SPL effective 2026-01-20, version 15)↗[عمومی]
• FDA NaHCO3 1.26% — Sodium bicarbonate injection 12.6 mg/mL (0.150 mEq/mL) (Baxter) — Prescribing Information (SPL effective 2026-08-14, version 1)↗[عمومی]
• FDA KCl oral solution — Potassium chloride oral solution 10%/20% (Granules) — Prescribing Information (SPL effective 2026-10-08, version 5)↗[عمومی]
• FDA KCl ER tablet — Potassium chloride extended-release tablets 10 mEq (Granules) — Prescribing Information (SPL effective 2026-10-07, version 5)↗[عمومی]
• FDA KCl concentrate — Potassium chloride for injection concentrate 2 mEq/mL (Hospira) — Prescribing Information (SPL effective 2026-07-01, version 23)↗[عمومی]
• FDA Samsca — Samsca (tolvaptan) tablets — Prescribing Information (SPL effective 2026-05-07, version 23)↗[عمومی]
• FDA Streptomycin — Streptomycin for injection 1 g (XGen) — Prescribing Information (SPL effective 2026-01-21, version 15)↗[عمومی]
• FDA Preparation H oint. — Preparation H ointment (phenylephrine/petrolatum/mineral oil) — Drug Facts (SPL effective 2024-02-29, version 15)↗[عمومی]
• FDA HC suppository — Hydrocortisone acetate rectal suppositories 25/30 mg (Aarna) — Prescribing Information (SPL effective 2026-04-16, version 1)↗[عمومی]
• FDA Rectiv — Rectiv (nitroglycerin 0.4%) ointment — Prescribing Information (SPL effective 2026-09-08, version 16)↗[عمومی]
• FDA Xdemvy — Xdemvy (lotilaner 0.25%) ophthalmic solution — Prescribing Information (SPL effective 2024-08-10, version 3)↗[عمومی]
• FDA Xenical — Xenical (orlistat) 120 mg capsules — Prescribing Information (SPL effective 2026-01-09, version 10)↗[عمومی]
• FDA Wegovy — Wegovy (semaglutide) injection and tablets — Prescribing Information (SPL effective 2026-06-18, version 19)↗[عمومی]
• FDA Saxenda — Saxenda (liraglutide) injection — Prescribing Information (SPL effective 2026-02-25, version 22)↗[عمومی]
• FDA Zepbound — Zepbound (tirzepatide) injection — Prescribing Information (SPL effective 2026-08-28, version 40)↗[عمومی]
• FDA Opzelura — Opzelura (ruxolitinib 1.5%) cream — Prescribing Information (SPL effective 2026-06-30, version 14)↗[عمومی]
• FDA Qbrexza — Qbrexza (glycopyrronium 2.4%) cloth — Prescribing Information (SPL effective 2026-05-21, version 5)↗[عمومی]
• FDA Zelsuvmi — Zelsuvmi (berdazimer 10.3%) topical gel — Prescribing Information (SPL effective 2025-07-08, version 3)↗[عمومی]
• FDA Rabeprazole — Rabeprazole sodium delayed-release tablets — Prescribing Information (SPL effective 2026-08-28, version 19)↗[عمومی]
• FDA Granisetron tab — Granisetron hydrochloride tablets 1 mg — Prescribing Information (SPL effective 2024-02-29, version 12)↗[عمومی]
• FDA Prasugrel — Prasugrel tablets 5/10 mg — Prescribing Information (SPL effective 2026-04-08, version 9)↗[عمومی]
• FDA Doxazosin — Doxazosin tablets (Apotex) — Prescribing Information (SPL effective 2026-09-10, version 16)↗[عمومی]
• FDA Terazosin — Terazosin capsules — Prescribing Information (SPL effective 2026-09-03, version 1)↗[عمومی]
• FDA Sotalol — Sotalol hydrochloride tablets (Apotex) — Prescribing Information (SPL effective 2026-09-17, version 18)↗[عمومی]
• FDA Propafenone — Propafenone hydrochloride tablets — Prescribing Information (SPL effective 2025-09-01, version 3)↗[عمومی]
• FDA Flecainide — Flecainide acetate tablets — Prescribing Information (SPL effective 2026-06-11, version 11)↗[عمومی]
• FDA Amiloride — Amiloride hydrochloride tablets 5 mg — Prescribing Information (SPL effective 2026-07-28, version 13)↗[عمومی]
• FDA Metolazone — Metolazone tablets 2.5/5/10 mg — Prescribing Information (SPL effective 2026-04-01, version 4)↗[عمومی]
• FDA Humalog — Humalog (insulin lispro) injection — Prescribing Information (SPL effective 2026-06-16, version 87)↗[عمومی]
• FDA Tresiba — Tresiba (insulin degludec) injection — Prescribing Information (SPL effective 2022-07-01, version 14)↗[عمومی]
• FDA Trulicity — Trulicity (dulaglutide) injection — Prescribing Information (SPL effective 2026-06-16, version 62)↗[عمومی]
• FDA Forteo — Forteo (teriparatide) injection — Prescribing Information (SPL effective 2026-08-03, version 44)↗[عمومی]
• FDA Ibandronate — Ibandronate sodium tablets 150 mg — Prescribing Information (SPL effective 2026-08-26, version 6)↗[عمومی]
• FDA Liothyronine — Liothyronine sodium tablets 5/25/50 mcg — Prescribing Information (SPL effective 2020-07-01, version 4)↗[عمومی]
• FDA Octreotide — Octreotide acetate injection — Prescribing Information (SPL effective 2026-01-13, version 12)↗[عمومی]
• FDA Meropenem — Meropenem for injection 500 mg / 1 g — Prescribing Information (SPL effective 2020-05-29, version 6)↗[عمومی]
• FDA Primaxin — Primaxin (imipenem and cilastatin) for injection — Prescribing Information (SPL effective 2024-07-05, version 34)↗[عمومی]
• FDA Pip-tazo — Piperacillin and tazobactam for injection 40.5 g pharmacy bulk — Prescribing Information (SPL effective 2026-10-05, version 8)↗[عمومی]
• FDA Cefepime — Cefepime for injection 1 g / 2 g — Prescribing Information (SPL effective 2026-06-23, version 17)↗[عمومی]
• FDA Linezolid tab — Linezolid tablets 600 mg — Prescribing Information (SPL effective 2026-08-24, version 3)↗[عمومی]
• FDA Coly-Mycin M — Coly-Mycin M Parenteral (colistimethate) 150 mg — Prescribing Information (SPL effective 2026-06-08, version 27)↗[عمومی]
• FDA Tivicay — Tivicay / Tivicay PD (dolutegravir) — Prescribing Information (SPL effective 2026-08-25, version 34)↗[عمومی]
• FDA Lamivudine — Lamivudine tablets 150/300 mg (Apotex) — Prescribing Information (SPL effective 2026-09-14, version 27)↗[عمومی]
• FDA Retrovir — Retrovir (zidovudine) capsules, tablets and syrup — Prescribing Information (SPL effective 2024-11-13, version 33)↗[عمومی]
• FDA Hydromorphone tab — Hydromorphone hydrochloride tablets 2/4/8 mg (SpecGx) — Prescribing Information (SPL effective 2026-07-02, version 29)↗[عمومی]
• FDA Nucynta — Nucynta (tapentadol) tablets — Prescribing Information (SPL effective 2025-12-30, version 7)↗[عمومی]
• FDA Fentanyl inj. — Fentanyl citrate injection 50 mcg/mL — Prescribing Information (SPL effective 2026-08-24, version 35)↗[عمومی]
• FDA Orphenadrine ER — Orphenadrine citrate extended-release tablets 100 mg (Lupin) — Prescribing Information (SPL effective 2025-09-10, version 15)↗[عمومی]
• FDA Desvenlafaxine — Desvenlafaxine extended-release tablets — Prescribing Information (SPL effective 2026-08-21, version 7)↗[عمومی]
• FDA Invega — Invega (paliperidone) extended-release tablets — Prescribing Information (SPL effective 2025-01-31, version 43)↗[عمومی]
• FDA Latuda — Latuda (lurasidone) tablets — Prescribing Information (SPL effective 2025-01-31, version 37)↗[عمومی]
• FDA Zonegran — Zonegran (zonisamide) capsules 25/100 mg — Prescribing Information (SPL effective 2026-09-23, version 13)↗[عمومی]
• FDA Briviact — Briviact (brivaracetam) tablets, oral solution and injection — Prescribing Information (SPL effective 2026-08-20, version 27)↗[عمومی]
• FDA Daliresp — Daliresp (roflumilast) tablets — Prescribing Information (SPL effective 2020-03-12, version 15)↗[عمومی]
• FDA Avodart — Avodart (dutasteride) 0.5 mg capsules — Prescribing Information (SPL effective 2025-03-12, version 4)↗[عمومی]
• FDA Myrbetriq — Myrbetriq (mirabegron) extended-release tablets and granules — Prescribing Information (SPL effective 2024-08-01, version 17)↗[عمومی]
• FDA Veregen — Veregen (sinecatechins) 15% ointment — Prescribing Information (SPL effective 2022-11-10, version 1)↗[عمومی]
• FDA RID kit — RID lice treatment (pyrethrum extract 0.33% + piperonyl butoxide 4%) — Drug Facts (SPL effective 2026-06-25, version 5)↗[عمومی]
• FDA Ertapenem — Ertapenem for injection 1 g (Apotex) — Prescribing Information (SPL effective 2026-10-01, version 1)↗[عمومی]
• FDA Amphotericin B — Amphotericin B for injection 50 mg (conventional, X-Gen) — Prescribing Information (SPL effective 2022-01-03, version 13)↗[عمومی]
• FDA Cresemba — Cresemba (isavuconazonium sulfate) capsules and injection — Prescribing Information (SPL effective 2025-04-25, version 21)↗[عمومی]
• FDA Riluzole — Riluzole tablets 50 mg — Prescribing Information (SPL effective 2026-10-12, version 9)↗[عمومی]
• FDA Radicava — Radicava / Radicava ORS (edaravone) — Prescribing Information (SPL effective 2026-05-05, version 29)↗[عمومی]
• FDA Tetrabenazine — Tetrabenazine tablets 12.5/25 mg (Apotex) — Prescribing Information (SPL effective 2026-09-18, version 7)↗[عمومی]
• FDA Austedo — Austedo / Austedo XR (deutetrabenazine) — Prescribing Information (SPL effective 2025-02-28, version 35)↗[عمومی]
• FDA Ingrezza — Ingrezza / Ingrezza Sprinkle (valbenazine) capsules — Prescribing Information (SPL effective 2026-04-17, version 34)↗[عمومی]
• FDA Emflaza — Emflaza (deflazacort) tablets and oral suspension — Prescribing Information (SPL effective 2026-10-13, version 22)↗[عمومی]
• FDA Firdapse — Firdapse (amifampridine) 10 mg tablets — Prescribing Information (SPL effective 2026-04-16, version 15)↗[عمومی]
• FDA Keveyis — Keveyis (dichlorphenamide) 50 mg tablets — Prescribing Information (SPL effective 2026-03-04, version 9)↗[عمومی]
• FDA Tecfidera — Tecfidera (dimethyl fumarate) delayed-release capsules — Prescribing Information (SPL effective 2025-06-04, version 55)↗[عمومی]
• FDA Aubagio — Aubagio (teriflunomide) tablets — Prescribing Information (SPL effective 2026-02-20, version 28)↗[عمومی]
• FDA Gilenya — Gilenya (fingolimod) capsules — Prescribing Information (SPL effective 2026-07-22, version 40)↗[عمومی]
• FDA Diprivan — Diprivan (propofol) injectable emulsion — Prescribing Information (SPL effective 2025-09-11, version 10)↗[عمومی]
• FDA Ketamine — Ketamine hydrochloride injection (Eugia) — Prescribing Information (SPL effective 2026-09-24, version 7)↗[عمومی]
• FDA Amidate — Amidate (etomidate) injection 2 mg/mL — Prescribing Information (SPL effective 2026-05-20, version 27)↗[عمومی]
• FDA Precedex — Precedex (dexmedetomidine) in 0.9% NaCl 4 mcg/mL — Prescribing Information (SPL effective 2026-06-17, version 6)↗[عمومی]
• FDA Quelicin — Quelicin (succinylcholine) injection 20 mg/mL — Prescribing Information (SPL effective 2026-08-18, version 31)↗[عمومی]
• FDA Rocuronium — Rocuronium bromide injection 10 mg/mL (Baxter) — Prescribing Information (SPL effective 2026-10-01, version 1)↗[عمومی]
• FDA Neostigmine — Neostigmine methylsulfate injection 0.5/1 mg/mL (Par) — Prescribing Information (SPL effective 2026-10-09, version 11)↗[عمومی]
• FDA Bridion — Bridion (sugammadex) injection 100 mg/mL — Prescribing Information (SPL effective 2026-03-13, version 26)↗[عمومی]
• FDA Marcaine Spinal — Marcaine Spinal (bupivacaine 0.75% in dextrose 8.25%) — Prescribing Information (SPL effective 2026-06-23, version 27)↗[عمومی]
• FDA Marcaine — Marcaine (bupivacaine hydrochloride) injection 0.25/0.5/0.75% — Prescribing Information (SPL effective 2026-06-24, version 1)↗[عمومی]
• FDA Fentanyl patch — Fentanyl transdermal system (SpecGx) — Prescribing Information (SPL effective 2026-04-30, version 58)↗[عمومی]
• FDA IPOL — IPOL (inactivated poliovirus vaccine) — Prescribing Information (SPL effective 2026-06-10, version 15)↗[عمومی]
• FDA Rotarix — Rotarix (rotavirus vaccine, live, oral) — Prescribing Information (SPL effective 2026-09-25, version 32)↗[عمومی]
• FDA Menveo — Menveo (meningococcal ACWY conjugate vaccine) — Prescribing Information (SPL effective 2025-03-31, version 20)↗[عمومی]
• FDA Shingrix — Shingrix (zoster vaccine recombinant, adjuvanted) — Prescribing Information (SPL effective 2026-08-31, version 24)↗[عمومی]
• FDA Arexvy — Arexvy (RSV vaccine recombinant, adjuvanted) — Prescribing Information (SPL effective 2026-07-27, version 13)↗[عمومی]
• FDA Comirnaty — Comirnaty (COVID-19 vaccine, mRNA) — Prescribing Information (SPL effective 2026-09-02, version 22)↗[عمومی]
• FDA BCG vaccine — BCG vaccine (Tice strain, percutaneous) — Prescribing Information (SPL effective 2024-10-11, version 20)↗[عمومی]
• FDA Tubersol — Tubersol (tuberculin PPD, Mantoux) — Prescribing Information (SPL effective 2026-05-01, version 18)↗[عمومی]
• FDA Humira — Humira (adalimumab) injection — Prescribing Information (SPL effective 2025-12-23, version 4)↗[عمومی]
• FDA Enbrel — Enbrel (etanercept) — Prescribing Information (SPL effective 2026-05-11, version 218)↗[عمومی]
• FDA Remicade — Remicade (infliximab) 100 mg vial — Prescribing Information (SPL effective 2025-06-03, version 37)↗[عمومی]
• FDA Rituxan — Rituxan (rituximab) IV — Prescribing Information (SPL effective 2025-01-06, version 36)↗[عمومی]
• FDA Dupixent — Dupixent (dupilumab) injection — Prescribing Information (SPL effective 2026-04-22, version 60)↗[عمومی]
• FDA Xolair — Xolair (omalizumab) — Prescribing Information (SPL effective 2026-08-13, version 32)↗[عمومی]
• FDA Stelara — Stelara (ustekinumab) — Prescribing Information (SPL effective 2026-09-08, version 49)↗[عمومی]
• FDA Cosentyx — Cosentyx (secukinumab) — Prescribing Information (SPL effective 2026-08-25, version 30)↗[عمومی]
• FDA Mycophenolate — Mycophenolate mofetil capsules 250 mg — Prescribing Information (SPL effective 2026-09-23, version 3)↗[عمومی]
• FDA Prograf — Prograf (tacrolimus) capsules, granules and injection — Prescribing Information (SPL effective 2023-08-25, version 30)↗[عمومی]
• FDA Neoral — Neoral (cyclosporine, modified) capsules and oral solution — Prescribing Information (SPL effective 2026-08-10, version 30)↗[عمومی]
• FDA Xeljanz — Xeljanz / Xeljanz XR (tofacitinib) — Prescribing Information (SPL effective 2026-09-25, version 55)↗[عمومی]
• FDA Olumiant — Olumiant (baricitinib) tablets — Prescribing Information (SPL effective 2026-09-25, version 31)↗[عمومی]
• FDA Rinvoq — Rinvoq (upadacitinib) extended-release tablets — Prescribing Information (SPL effective 2026-06-30, version 101)↗[عمومی]
• FDA Otezla — Otezla / Otezla XR (apremilast) — Prescribing Information (SPL effective 2026-09-02, version 38)↗[عمومی]
• FDA Tamoxifen — Tamoxifen citrate tablets 10/20 mg (Mylan) — Prescribing Information (SPL effective 2021-07-02, version 14)↗[عمومی]
• FDA Anastrozole — Anastrozole tablets 1 mg — Prescribing Information (SPL effective 2026-08-18, version 14)↗[عمومی]
• FDA Bicalutamide — Bicalutamide tablets 50 mg — Prescribing Information (SPL effective 2026-02-27, version 3)↗[عمومی]
• FDA Imatinib — Imatinib mesylate tablets 100/400 mg — Prescribing Information (SPL effective 2026-08-31, version 5)↗[عمومی]
• FDA Capecitabine — Capecitabine tablets 150/500 mg — Prescribing Information (SPL effective 2026-07-21, version 2)↗[عمومی]
• FDA Neupogen — Neupogen (filgrastim) injection — Prescribing Information (SPL effective 2026-07-23, version 166)↗[عمومی]
• FDA Savaysa — Savaysa (edoxaban) tablets — Prescribing Information (SPL effective 2025-07-10, version 28)↗[عمومی]
• FDA Fondaparinux — Fondaparinux sodium injection (Mylan) — Prescribing Information (SPL effective 2024-12-15, version 12)↗[عمومی]
• FDA Argatroban — Argatroban in 0.9% NaCl 1 mg/mL — Prescribing Information (SPL effective 2026-09-22, version 6)↗[عمومی]
• FDA Bivalirudin — Bivalirudin for injection 250 mg — Prescribing Information (SPL effective 2026-08-20, version 2)↗[عمومی]
• FDA TNKase — TNKase (tenecteplase) 25 mg / 50 mg — Prescribing Information (SPL effective 2025-12-15, version 4)↗[عمومی]
• FDA Repatha — Repatha (evolocumab) — Prescribing Information (SPL effective 2026-08-19, version 32)↗[عمومی]
• FDA Praluent — Praluent (alirocumab) — Prescribing Information (SPL effective 2026-07-07, version 35)↗[عمومی]
• FDA Leqvio — Leqvio (inclisiran) 284 mg/1.5 mL — Prescribing Information (SPL effective 2026-08-19, version 13)↗[عمومی]
• FDA Nexletol — Nexletol (bempedoic acid) 180 mg — Prescribing Information (SPL effective 2026-06-25, version 20)↗[عمومی]
• FDA Vascepa — Vascepa (icosapent ethyl) capsules — Prescribing Information (SPL effective 2026-03-23, version 21)↗[عمومی]
• FDA Kerendia — Kerendia (finerenone) tablets — Prescribing Information (SPL effective 2026-09-21, version 15)↗[عمومی]
• FDA Verquvo — Verquvo (vericiguat) tablets — Prescribing Information (SPL effective 2026-01-21, version 13)↗[عمومی]
• FDA Fycompa — Fycompa (perampanel) tablets and oral suspension — Prescribing Information (SPL effective 2022-12-28, version 60)↗[عمومی]
• FDA Xcopri — Xcopri (cenobamate) tablets — Prescribing Information (SPL effective 2025-08-25, version 46)↗[عمومی]
• FDA Rufinamide susp. — Rufinamide oral suspension 40 mg/mL — Prescribing Information (SPL effective 2026-08-07, version 9)↗[عمومی]
• FDA Vigabatrin — Vigabatrin for oral solution 500 mg packet — Prescribing Information (SPL effective 2026-01-20, version 30)↗[عمومی]
• FDA Entacapone — Entacapone tablets 200 mg (Macleods) — Prescribing Information (SPL effective 2026-05-13, version 7)↗[عمومی]
• FDA Ongentys — Ongentys (opicapone) capsules — Prescribing Information (SPL effective 2025-10-15, version 9)↗[عمومی]
• FDA Xadago — Xadago (safinamide) tablets — Prescribing Information (SPL effective 2026-10-05, version 22)↗[عمومی]
• FDA Modafinil — Modafinil tablets 100/200 mg — Prescribing Information (SPL effective 2026-09-03, version 14)↗[عمومی]
• FDA Xyrem — Xyrem (sodium oxybate) oral solution 0.5 g/mL — Prescribing Information (SPL effective 2025-07-01, version 27)↗[عمومی]
• FDA Wakix — Wakix (pitolisant) tablets — Prescribing Information (SPL effective 2026-02-13, version 18)↗[عمومی]
• FDA Belsomra — Belsomra (suvorexant) tablets — Prescribing Information (SPL effective 2025-03-10, version 21)↗[عمومی]
• FDA Aimovig — Aimovig (erenumab) — Prescribing Information (SPL effective 2026-07-14, version 25)↗[عمومی]
• FDA Emgality — Emgality (galcanezumab) — Prescribing Information (SPL effective 2026-06-05, version 17)↗[عمومی]
• FDA Ubrelvy — Ubrelvy (ubrogepant) tablets — Prescribing Information (SPL effective 2025-06-05, version 28)↗[عمومی]
• FDA Vraylar — Vraylar (cariprazine) capsules — Prescribing Information (SPL effective 2025-12-18, version 32)↗[عمومی]
• FDA Rexulti — Rexulti (brexpiprazole) tablets — Prescribing Information (SPL effective 2026-05-06, version 26)↗[عمومی]
• FDA Spravato — Spravato (esketamine) nasal spray — Prescribing Information (SPL effective 2026-09-22, version 21)↗[عمومی]
• FDA Cancidas — Cancidas (caspofungin) for injection 50/70 mg — Prescribing Information (SPL effective 2024-10-11, version 42)↗[عمومی]
• FDA Veklury — Veklury (remdesivir) for injection 100 mg — Prescribing Information (SPL effective 2026-07-29, version 24)↗[عمومی]
• FDA Prepidil — Prepidil (dinoprostone 0.5 mg) endocervical gel — Prescribing Information (SPL effective 2025-10-22, version 23)↗[عمومی]
• FDA Levemir — Levemir (insulin detemir) — Prescribing Information (repackager listing) (SPL effective 2024-10-09, version 24)↗[عمومی]
• FDA Apidra — Apidra (insulin glulisine) — Prescribing Information (SPL effective 2025-11-25, version 28)↗[عمومی]
• FDA Evenity — Evenity (romosozumab) 105 mg/1.17 mL — Prescribing Information (SPL effective 2026-07-16, version 21)↗[عمومی]
• FDA Cardene IV — Cardene I.V. (nicardipine) premixed 0.1/0.2 mg/mL — Prescribing Information (SPL effective 2026-04-13, version 11)↗[عمومی]
• FDA Cleviprex — Cleviprex (clevidipine) emulsion 0.5 mg/mL — Prescribing Information (SPL effective 2022-11-09, version 4)↗[عمومی]
• FDA Nipride RTU — Nipride RTU (sodium nitroprusside) 0.2/0.5 mg/mL — Prescribing Information (SPL effective 2018-07-20, version 6)↗[عمومی]
• FDA Milrinone — Milrinone lactate injection 1 mg/mL (Mullan) — Prescribing Information (SPL effective 2026-07-27, version 5)↗[عمومی]
• FDA Isoproterenol — Isoproterenol hydrochloride injection 0.2 mg/mL (Amphastar) — Prescribing Information (SPL effective 2022-10-01, version 3)↗[عمومی]
• FDA Kengreal — Kengreal (cangrelor) for injection 50 mg — Prescribing Information (SPL effective 2025-10-21, version 10)↗[عمومی]
• FDA Fragmin — Fragmin (dalteparin) injection — Prescribing Information (SPL effective 2025-09-30, version 27)↗[عمومی]
• FDA Praxbind — Praxbind (idarucizumab) 2.5 g/50 mL — Prescribing Information (SPL effective 2024-01-23, version 8)↗[عمومی]
• FDA Andexxa — Andexxa (andexanet alfa) 200 mg vial — Prescribing Information (SPL effective 2025-05-23, version 7)↗[عمومی]
• FDA Aminocaproic acid — Aminocaproic acid tablets 500/1000 mg — Prescribing Information (SPL effective 2026-09-09, version 1)↗[عمومی]
• FDA Dipyridamole — Dipyridamole tablets 25/50/75 mg (Amneal) — Prescribing Information (SPL effective 2026-04-15, version 8)↗[عمومی]
• FDA Ryanodex — Ryanodex (dantrolene sodium) 250 mg for injectable suspension — Prescribing Information (SPL effective 2024-10-30, version 10)↗[عمومی]
• FDA Multaq — Multaq (dronedarone) 400 mg tablets — Prescribing Information (SPL effective 2025-05-29, version 37)↗[عمومی]
• FDA Tikosyn — Tikosyn (dofetilide) capsules — Prescribing Information (SPL effective 2026-04-21, version 30)↗[عمومی]
• FDA Nadolol — Nadolol tablets 20/40/80 mg — Prescribing Information (SPL effective 2026-09-07, version 3)↗[عمومی]
• FDA Edecrin — Edecrin (ethacrynic acid) tablets / Sodium Edecrin IV — Prescribing Information (SPL effective 2020-08-31, version 10)↗[عمومی]
• FDA Cefoxitin — Cefoxitin for injection (WG Critical Care) — Prescribing Information (SPL effective 2026-08-24, version 8)↗[عمومی]
• FDA Azactam — Azactam (aztreonam) for injection — Prescribing Information (SPL effective 2025-12-15, version 15)↗[عمومی]
• FDA Tygacil — Tygacil (tigecycline) 50 mg — Prescribing Information (SPL effective 2025-11-18, version 50)↗[عمومی]
• FDA Cubicin RF — Cubicin RF (daptomycin) 500 mg — Prescribing Information (SPL effective 2025-03-17, version 22)↗[عمومی]
• FDA Sivextro — Sivextro (tedizolid) tablets and injection — Prescribing Information (SPL effective 2026-02-27, version 34)↗[عمومی]
• FDA Dificid — Dificid (fidaxomicin) tablets and oral suspension — Prescribing Information (SPL effective 2024-10-16, version 22)↗[عمومی]
• FDA Dapsone — Dapsone tablets 25/100 mg (Macleods) — Prescribing Information (SPL effective 2026-07-20, version 1)↗[عمومی]
• FDA Sirturo — Sirturo (bedaquiline) 20/100 mg tablets — Prescribing Information (SPL effective 2025-10-17, version 33)↗[عمومی]
• FDA Noxafil — Noxafil (posaconazole) injection, delayed-release tablets, oral suspension — Prescribing Information (SPL effective 2026-02-13, version 56)↗[عمومی]
• FDA Micafungin premix — Micafungin in sodium chloride injection 1 mg/mL (Baxter) — Prescribing Information (SPL effective 2023-09-29, version 6)↗[عمومی]
• FDA Eraxis — Eraxis (anidulafungin) 50/100 mg — Prescribing Information (SPL effective 2025-08-19, version 24)↗[عمومی]
• FDA Flucytosine — Flucytosine capsules 250/500 mg — Prescribing Information (SPL effective 2026-01-08, version 4)↗[عمومی]
• FDA Relenza — Relenza (zanamivir) inhalation powder — Prescribing Information (SPL effective 2023-10-24, version 34)↗[عمومی]
• FDA Ganciclovir — Ganciclovir for injection 500 mg (Par) — Prescribing Information (SPL effective 2026-09-25, version 8)↗[عمومی]
• FDA Valcyte — Valcyte (valganciclovir) tablets and oral solution — Prescribing Information (SPL effective 2025-12-08, version 24)↗[عمومی]
• FDA Foscavir — Foscavir (foscarnet) 24 mg/mL — Prescribing Information (SPL effective 2025-12-11, version 16)↗[عمومی]
• FDA Vemlidy — Vemlidy (tenofovir alafenamide) 25 mg — Prescribing Information (SPL effective 2025-07-14, version 17)↗[عمومی]
• FDA Ribavirin caps — Ribavirin capsules 200 mg (Aurobindo) — Prescribing Information (SPL effective 2024-02-06, version 21)↗[عمومی]
• FDA Efavirenz — Efavirenz tablets 600 mg (Cipla) — Prescribing Information (SPL effective 2024-03-31, version 7)↗[عمومی]
• FDA Isentress — Isentress / Isentress HD (raltegravir) — Prescribing Information (SPL effective 2024-10-18, version 71)↗[عمومی]
• FDA Biktarvy — Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) — Prescribing Information (SPL effective 2026-09-09, version 26)↗[عمومی]
• FDA Prezista — Prezista (darunavir) tablets and oral suspension — Prescribing Information (SPL effective 2025-08-29, version 58)↗[عمومی]
• FDA Reyataz — Reyataz (atazanavir) capsules and oral powder — Prescribing Information (SPL effective 2024-12-05, version 37)↗[عمومی]
• FDA Abacavir — Abacavir tablets 300 mg (Aurobindo) — Prescribing Information (SPL effective 2026-09-21, version 17)↗[عمومی]
• FDA Edurant — Edurant / Edurant PED (rilpivirine) — Prescribing Information (SPL effective 2025-08-28, version 28)↗[عمومی]
• FDA Cabenuva — Cabenuva (cabotegravir + rilpivirine extended-release injectable) — Prescribing Information (SPL effective 2025-11-26, version 16)↗[عمومی]
• FDA Daraprim — Daraprim (pyrimethamine) 25 mg tablets — Prescribing Information (SPL effective 2023-12-07, version 1)↗[عمومی]
• FDA Genotropin — Genotropin (somatropin) for injection — Prescribing Information (SPL effective 2026-08-04, version 37)↗[عمومی]
• FDA Lupron Depot — Lupron Depot 7.5/22.5/30/45 mg (leuprolide acetate, prostate cancer) — Prescribing Information (SPL effective 2026-03-15, version 1543)↗[عمومی]
• FDA Zoladex 3.6 — Zoladex (goserelin implant) 3.6 mg — Prescribing Information (SPL effective 2026-03-24, version 9)↗[عمومی]
• FDA Firmagon — Firmagon (degarelix) for injection — Prescribing Information (SPL effective 2024-01-30, version 18)↗[عمومی]
• FDA Signifor — Signifor (pasireotide) injection — Prescribing Information (SPL effective 2026-02-17, version 20)↗[عمومی]
• FDA Zemplar injection — Zemplar (paricalcitol) injection — Prescribing Information (SPL effective 2024-08-01, version 1483)↗[عمومی]
• FDA Invokana — Invokana (canagliflozin) tablets — Prescribing Information (SPL effective 2026-06-11, version 32)↗[عمومی]
• FDA Steglatro — Steglatro (ertugliflozin) tablets — Prescribing Information (SPL effective 2026-06-03, version 17)↗[عمومی]
• FDA Byetta — Byetta (exenatide) injection — Prescribing Information (SPL effective 2025-09-02, version 26)↗[عمومی]
• FDA Symlin — Symlin (pramlintide) injection — Prescribing Information (SPL effective 2019-12-18, version 18)↗[عمومی]
• FDA Proglycem — Proglycem (diazoxide) oral suspension 50 mg/mL — Prescribing Information (SPL effective 2026-10-06, version 17)↗[عمومی]
• FDA Aranesp — Aranesp (darbepoetin alfa) injection — Prescribing Information (SPL effective 2026-07-07, version 161)↗[عمومی]
• FDA Cyanocobalamin inj — Cyanocobalamin injection 1000 mcg/mL (American Regent/BluePoint) — Prescribing Information (SPL effective 2026-10-09, version 3)↗[عمومی]
• FDA Promacta — Promacta (eltrombopag) tablets and oral suspension — Prescribing Information (SPL effective 2025-12-18, version 31)↗[عمومی]
• FDA Nplate — Nplate (romiplostim) for injection — Prescribing Information (SPL effective 2026-06-23, version 162)↗[عمومی]
• FDA Hemlibra — Hemlibra (emicizumab-kxwh) injection — Prescribing Information (SPL effective 2025-07-11, version 17)↗[عمومی]
• FDA Saphris — Saphris (asenapine) sublingual tablets — Prescribing Information (SPL effective 2025-01-31, version 22)↗[عمومی]
• FDA Fanapt — Fanapt (iloperidone) tablets — Prescribing Information (SPL effective 2026-05-06, version 35)↗[عمومی]
• FDA Caplyta — Caplyta (lumateperone) capsules — Prescribing Information (SPL effective 2025-06-20, version 27)↗[عمومی]
• FDA Fluphenazine — Fluphenazine hydrochloride tablets USP — Prescribing Information (SPL effective 2026-04-14, version 13)↗[عمومی]
• FDA Loxapine — Loxapine capsules USP (Watson/Actavis) — Prescribing Information (SPL effective 2025-03-31, version 20)↗[عمومی]
• FDA Pimozide — Pimozide tablets USP 1/2 mg (Par) — Prescribing Information (SPL effective 2026-08-12, version 5)↗[عمومی]
• FDA Aptiom — Aptiom (eslicarbazepine acetate) tablets — Prescribing Information (SPL effective 2023-11-10, version 16)↗[عمومی]
• FDA Felbatol — Felbatol (felbamate) tablets and oral suspension — Prescribing Information (SPL effective 2025-08-15, version 16)↗[عمومی]
• FDA Diacomit — Diacomit (stiripentol) capsules and powder for oral suspension — Prescribing Information (SPL effective 2026-04-27, version 8)↗[عمومی]
• FDA Fintepla — Fintepla (fenfluramine) oral solution 2.2 mg/mL — Prescribing Information (SPL effective 2025-10-27, version 16)↗[عمومی]
• FDA Primidone — Primidone tablets USP 50/250 mg — Prescribing Information (SPL effective 2026-09-01, version 1)↗[عمومی]
• FDA Galantamine — Galantamine tablets USP 4/8/12 mg — Prescribing Information (SPL effective 2026-06-01, version 8)↗[عمومی]
• FDA Leqembi — Leqembi / Leqembi Iqlik (lecanemab-irmb) — Prescribing Information (SPL effective 2026-07-21, version 24)↗[عمومی]
• FDA Neupro — Neupro (rotigotine transdermal system) — Prescribing Information (SPL effective 2026-09-10, version 22)↗[عمومی]
• FDA Apokyn — Apokyn (apomorphine hydrochloride) injection 10 mg/mL — Prescribing Information (SPL effective 2024-10-10, version 21)↗[عمومی]
• FDA Selegiline caps — Selegiline hydrochloride capsules 5 mg — Prescribing Information (SPL effective 2026-09-17, version 9)↗[عمومی]
• FDA Benztropine tabs — Benztropine mesylate tablets USP — Prescribing Information (SPL effective 2026-08-20, version 11)↗[عمومی]
• FDA Botox — Botox (onabotulinumtoxinA) for injection — Prescribing Information (SPL effective 2023-11-18, version 62)↗[عمومی]
• FDA Zolmitriptan — Zolmitriptan tablets 2.5/5 mg — Prescribing Information (SPL effective 2026-04-16, version 7)↗[عمومی]
• FDA Relpax — Relpax (eletriptan) tablets — Prescribing Information (SPL effective 2024-01-15, version 4)↗[عمومی]
• FDA Naratriptan — Naratriptan tablets 1/2.5 mg — Prescribing Information (SPL effective 2026-06-30, version 4)↗[عمومی]
• FDA Frovatriptan — Frovatriptan succinate tablets 2.5 mg — Prescribing Information (SPL effective 2026-06-27, version 2)↗[عمومی]
• FDA Reyvow — Reyvow (lasmiditan) tablets — Prescribing Information (SPL effective 2026-01-08, version 16)↗[عمومی]
• FDA Qulipta — Qulipta (atogepant) tablets — Prescribing Information (SPL effective 2025-09-30, version 19)↗[عمومی]
• FDA Ajovy — Ajovy (fremanezumab-vfrm) injection — Prescribing Information (SPL effective 2026-06-05, version 24)↗[عمومی]
• FDA Vyepti — Vyepti (eptinezumab-jjmr) injection — Prescribing Information (SPL effective 2026-06-05, version 32)↗[عمومی]
• FDA Viibryd — Viibryd (vilazodone) tablets — Prescribing Information (SPL effective 2023-10-01, version 34)↗[عمومی]
• FDA Fetzima — Fetzima (levomilnacipran) extended-release capsules — Prescribing Information (SPL effective 2024-04-30, version 33)↗[عمومی]
• FDA Savella — Savella (milnacipran) tablets — Prescribing Information (SPL effective 2025-09-10, version 41)↗[عمومی]
• FDA Nefazodone — Nefazodone hydrochloride tablets USP (Teva) — Prescribing Information (SPL effective 2025-07-31, version 12)↗[عمومی]
• FDA Nardil — Nardil (phenelzine sulfate) tablets 15 mg — Prescribing Information (SPL effective 2025-06-06, version 11)↗[عمومی]
• FDA Tranylcypromine — Tranylcypromine sulfate tablets 10 mg — Prescribing Information (SPL effective 2025-07-25, version 8)↗[عمومی]
• FDA Lunesta — Lunesta (eszopiclone) tablets — Prescribing Information (SPL effective 2025-01-08, version 2)↗[عمومی]
• FDA Zaleplon — Zaleplon capsules USP 5/10 mg — Prescribing Information (SPL effective 2019-08-26, version 11)↗[عمومی]
• FDA Rozerem — Rozerem (ramelteon) tablets 8 mg — Prescribing Information (SPL effective 2026-04-15, version 20)↗[عمومی]
• FDA Dayvigo — Dayvigo (lemborexant) tablets — Prescribing Information (SPL effective 2025-02-24, version 39)↗[عمومی]
• FDA Quviviq — Quviviq (daridorexant) tablets — Prescribing Information (SPL effective 2026-02-26, version 13)↗[عمومی]
• FDA Qelbree — Qelbree (viloxazine extended-release capsules) — Prescribing Information (SPL effective 2026-10-05, version 16)↗[عمومی]
• FDA Focalin — Focalin (dexmethylphenidate hydrochloride) tablets — Prescribing Information (SPL effective 2024-05-30, version 2)↗[عمومی]
• FDA Epidiolex — Epidiolex (cannabidiol) oral solution 100 mg/mL — Prescribing Information (SPL effective 2026-05-29, version 35)↗[عمومی]
• FDA Dexilant — Dexilant (dexlansoprazole) delayed-release capsules — Prescribing Information (SPL effective 2025-02-17, version 40)↗[عمومی]
• FDA Amitiza — Amitiza (lubiprostone) capsules — Prescribing Information (SPL effective 2026-07-10, version 4)↗[عمومی]
• FDA Trulance — Trulance (plecanatide) tablets 3 mg — Prescribing Information (SPL effective 2024-04-04, version 15)↗[عمومی]
• FDA Alosetron — Alosetron tablets 0.5/1 mg — Prescribing Information (SPL effective 2025-10-03, version 3)↗[عمومی]
• FDA Viberzi — Viberzi (eluxadoline) tablets — Prescribing Information (SPL effective 2024-07-16, version 28)↗[عمومی]
• FDA Entyvio — Entyvio (vedolizumab) for injection and subcutaneous injection — Prescribing Information (SPL effective 2026-04-29, version 26)↗[عمومی]
• FDA Emend — Emend (aprepitant) capsules and oral suspension — Prescribing Information (SPL effective 2024-07-05, version 42)↗[عمومی]
• FDA Fosaprepitant — Fosaprepitant for injection 150 mg — Prescribing Information (SPL effective 2026-10-06, version 8)↗[عمومی]
• FDA Palonosetron — Palonosetron hydrochloride injection 0.25 mg/5 mL — Prescribing Information (SPL effective 2026-08-25, version 8)↗[عمومی]
• FDA Marinol — Marinol (dronabinol) capsules — Prescribing Information (SPL effective 2023-02-14, version 5)↗[عمومی]
• FDA Incruse Ellipta — Incruse Ellipta (umeclidinium) inhalation powder — Prescribing Information (SPL effective 2023-12-13, version 27)↗[عمومی]
• FDA Tudorza Pressair — Tudorza Pressair (aclidinium bromide) inhalation powder — Prescribing Information (SPL effective 2022-08-01, version 2)↗[عمومی]
• FDA Striverdi Respimat — Striverdi Respimat (olodaterol) inhalation spray — Prescribing Information (SPL effective 2025-01-03, version 9)↗[عمومی]
• FDA Breo Ellipta — Breo Ellipta (fluticasone furoate/vilanterol) inhalation powder — Prescribing Information (SPL effective 2024-11-07, version 29)↗[عمومی]
• FDA Nucala — Nucala (mepolizumab) for injection and injection — Prescribing Information (SPL effective 2025-08-06, version 24)↗[عمومی]
• FDA Fasenra — Fasenra (benralizumab) injection — Prescribing Information (SPL effective 2026-05-13, version 27)↗[عمومی]
• FDA Tezspire — Tezspire (tezepelumab-ekko) injection — Prescribing Information (SPL effective 2025-10-17, version 16)↗[عمومی]
• FDA Zafirlukast — Zafirlukast tablets 10/20 mg — Prescribing Information (SPL effective 2026-03-16, version 7)↗[عمومی]
• FDA Pulmozyme — Pulmozyme (dornase alfa) inhalation solution — Prescribing Information (SPL effective 2025-12-17, version 24)↗[عمومی]
• FDA Glycopyrrolate inj — Glycopyrrolate injection USP 0.2 mg/mL (American Regent) — Prescribing Information (SPL effective 2024-02-07, version 12)↗[عمومی]
• FDA Probenecid — Probenecid tablets USP 500 mg — Prescribing Information (SPL effective 2026-01-28, version 5)↗[عمومی]
• FDA Krystexxa — Krystexxa (pegloticase) injection — Prescribing Information (SPL effective 2026-07-09, version 1149)↗[عمومی]
• FDA Benlysta — Benlysta (belimumab) for injection and injection — Prescribing Information (SPL effective 2026-08-21, version 38)↗[عمومی]
• FDA Kineret — Kineret (anakinra) injection — Prescribing Information (SPL effective 2026-04-03, version 24)↗[عمومی]
• FDA Actemra — Actemra (tocilizumab) injection — Prescribing Information (SPL effective 2025-12-16, version 53)↗[عمومی]
• FDA Orencia — Orencia (abatacept) for injection and injection — Prescribing Information (SPL effective 2025-11-13, version 35)↗[عمومی]
• FDA Cimzia — Cimzia (certolizumab pegol) — Prescribing Information (SPL effective 2026-02-24, version 47)↗[عمومی]
• FDA Simponi — Simponi (golimumab) injection — Prescribing Information (SPL effective 2026-09-17, version 43)↗[عمومی]
• FDA Taltz — Taltz (ixekizumab) injection — Prescribing Information (SPL effective 2026-01-22, version 40)↗[عمومی]
• FDA Tremfya — Tremfya (guselkumab) injection — Prescribing Information (SPL effective 2026-06-04, version 29)↗[عمومی]
• FDA Skyrizi — Skyrizi (risankizumab-rzaa) — Prescribing Information (SPL effective 2026-06-15, version 179)↗[عمومی]
• FDA Ilumya — Ilumya (tildrakizumab-asmn) injection — Prescribing Information (SPL effective 2026-10-05, version 20)↗[عمومی]
• FDA Tysabri — Tysabri (natalizumab) injection — Prescribing Information (SPL effective 2025-03-21, version 47)↗[عمومی]
• FDA Ocrevus — Ocrevus (ocrelizumab) injection for IV use — Prescribing Information (SPL effective 2026-05-14, version 24)↗[عمومی]
• FDA Kesimpta — Kesimpta (ofatumumab) injection — Prescribing Information (SPL effective 2026-04-01, version 11)↗[عمومی]
• FDA Mavenclad — Mavenclad (cladribine) tablets 10 mg — Prescribing Information (SPL effective 2026-05-27, version 10)↗[عمومی]
• FDA Mayzent — Mayzent (siponimod) tablets — Prescribing Information (SPL effective 2026-06-30, version 17)↗[عمومی]
• FDA Zeposia — Zeposia (ozanimod) capsules — Prescribing Information (SPL effective 2026-04-16, version 25)↗[عمومی]
• FDA Copaxone — Copaxone (glatiramer acetate) injection — Prescribing Information (SPL effective 2026-06-23, version 36)↗[عمومی]
• FDA Avonex — Avonex (interferon beta-1a) injection for IM use — Prescribing Information (SPL effective 2025-11-19, version 23)↗[عمومی]
• FDA Alfuzosin ER — Alfuzosin HCl extended-release tablets 10 mg (Apotex) — Prescribing Information (SPL effective 2026-09-03, version 18)↗[عمومی]
• FDA Silodosin — Silodosin capsules 4/8 mg — Prescribing Information (SPL effective 2026-08-18, version 3)↗[عمومی]
• FDA Darifenacin ER — Darifenacin extended-release tablets 7.5/15 mg — Prescribing Information (SPL effective 2026-02-10, version 10)↗[عمومی]
• FDA Trospium — Trospium chloride tablets 20 mg — Prescribing Information (SPL effective 2026-09-03, version 14)↗[عمومی]
• FDA Gemtesa — Gemtesa (vibegron) tablets 75 mg — Prescribing Information (SPL effective 2025-04-01, version 12)↗[عمومی]
• FDA Acitretin — Acitretin capsules USP 10/17.5/25 mg — Prescribing Information (SPL effective 2026-08-05, version 8)↗[عمومی]
• FDA Tazorac cream — Tazorac (tazarotene) cream 0.05%/0.1% — Prescribing Information (SPL effective 2025-11-13, version 6)↗[عمومی]
• FDA Jublia — Jublia (efinaconazole) topical solution 10% — Prescribing Information (SPL effective 2025-07-01, version 21)↗[عمومی]
• FDA Tavaborole — Tavaborole topical solution 5% — Prescribing Information (SPL effective 2025-09-15, version 7)↗[عمومی]
• FDA Lumigan 0.01% — Lumigan (bimatoprost ophthalmic solution) 0.01% — Prescribing Information (SPL effective 2024-06-22, version 19)↗[عمومی]
• FDA Travatan Z — Travatan Z (travoprost ophthalmic solution) 0.004% — Prescribing Information (SPL effective 2023-06-27, version 6)↗[عمومی]
• FDA Pilocarpine 1.25% — Pilocarpine HCl ophthalmic solution 1.25% — Prescribing Information (SPL effective 2025-06-02, version 6)↗[عمومی]
• FDA Xiidra — Xiidra (lifitegrast ophthalmic solution) 5% — Prescribing Information (SPL effective 2025-08-18, version 6)↗[عمومی]
• FDA Lucentis — Lucentis (ranibizumab) intravitreal injection — Prescribing Information (SPL effective 2025-11-21, version 27)↗[عمومی]
• FDA Eylea — Eylea (aflibercept) intravitreal injection 2 mg — Prescribing Information (SPL effective 2026-07-07, version 41)↗[عمومی]

SmPC بریتانیا (eMC / MHRA)

• UK SmPC Metoclopramide — Metoclopramide hydrochloride 5 mg/5 ml Oral Solution — Summary of Product Characteristics (Revised 26/01/2026)↗[عمومی]
• UK SmPC Domperidone — Domperidone 1 mg/ml Oral Suspension — Summary of Product Characteristics (Revised 04/11/2025)↗[عمومی]
• UK SmPC Neoclarityn — NeoClarityn (desloratadine) 0.5 mg/ml Oral Solution — Summary of Product Characteristics (Revised 01 January 2021)↗[عمومی]
• UK SmPC Piriton — Piriton Syrup (chlorphenamine maleate 2 mg/5 ml) — Summary of Product Characteristics (Revised 14 April 2023)↗[عمومی]
• UK SmPC Sytron — Sytron 27.5 mg iron per 5 ml Oral Solution (sodium feredetate) — Summary of Product Characteristics (Revised 01/05/2025)↗[عمومی]
• UK SmPC Thorens D3 — THORENS 10 000 I.U./ml oral drops (colecalciferol) — Summary of Product Characteristics (Revised 13 January 2022)↗[عمومی]
• UK SmPC Prednisolone — Prednisolone 10 mg/ml Oral Solution — Summary of Product Characteristics (Revised 11/2025)↗[عمومی]
• UK SmPC Movicol Paed — MOVICOL Paediatric Chocolate flavour 6.8 g powder for oral solution — Summary of Product Characteristics (Revised 11/03/2025)↗[عمومی]
• UK SmPC Budesonide neb — Budesonide 0.5 mg nebuliser suspension — Summary of Product Characteristics (Revised 14/05/2024)↗[عمومی]
• UK SmPC Diamicron 80 — Diamicron 80 mg Tablets — Summary of Product Characteristics (Revised 02/2020)↗[عمومی]
• UK SmPC Gliclazide MR 30 — Gliclazide Krka 30 mg modified-release tablets — Summary of Product Characteristics (Revised 24/10/2023)↗[عمومی]
• UK SmPC Serc 8 — Serc-8 (betahistine dihydrochloride 8 mg) tablets — Summary of Product Characteristics (Revised November 2025)↗[عمومی]
• UK SmPC Buscopan — Buscopan 10 mg Tablets — Summary of Product Characteristics (Revised 22/09/2025)↗[عمومی]
• UK SmPC Colofac — Colofac (mebeverine) 135 mg Coated Tablets — Summary of Product Characteristics (Revised Jun 2025)↗[عمومی]
• UK SmPC Fucidin cream — Fucidin 20 mg/g Cream — Summary of Product Characteristics (Revised 01 June 2026)↗[عمومی]
• UK SmPC Canesten cream — Canesten (clotrimazole 1%) Cream — Summary of Product Characteristics (Revised 07/06/2022)↗[عمومی]
• UK SmPC Canesten pess. — Canesten Thrush Pessary 500 mg — Summary of Product Characteristics (Revised 06/06/2023)↗[عمومی]
• UK SmPC Folic acid 5 mg — Folic Acid Tablets 5 mg — Summary of Product Characteristics (Revised 20/05/2026)↗[عمومی]
• UK SmPC Ferrous sulfate — Ferrous Sulfate Tablets 200 mg — Summary of Product Characteristics (Revised 01/09/2021)↗[عمومی]
• UK SmPC Hydroxocobalamin — Hydroxocobalamin 1 mg/ml Solution for Injection — Summary of Product Characteristics (Revised 23/01/2024)↗[عمومی]
• UK SmPC Adcal-D3 — Adcal-D3 chewable tablets — Summary of Product Characteristics (Revised 04/2025)↗[عمومی]
• UK SmPC Indapamide — Indapamide 2.5 mg Tablets — Summary of Product Characteristics (Revised 02/04/2026)↗[عمومی]
• UK SmPC Voltarol amp. — Voltarol Ampoules (diclofenac sodium 75 mg/3 mL) — Summary of Product Characteristics (Revised 9 September 2025)↗[عمومی]
• UK SmPC Buscopan amp. — Buscopan Ampoules (hyoscine butylbromide 20 mg/mL) — Summary of Product Characteristics (Revised 11/12/2025)↗[عمومی]
• UK SmPC Metronidazole — Metronidazole 200 mg/5 ml Oral Suspension — Summary of Product Characteristics (Revised 20/06/2023)↗[عمومی]
• UK SmPC Betnesol drops — Betnesol Eye, Ear and Nose Drops 0.1% — Summary of Product Characteristics (Revised 11/01/2021)↗[عمومی]
• UK SmPC Chloramphenicol — Minims Chloramphenicol 0.5% eye drops — Summary of Product Characteristics (Revised see eMC)↗[عمومی]
• UK SmPC Fucidin H — Fucidin H cream (fusidic acid 2% + hydrocortisone 1%) — Summary of Product Characteristics (Revised see eMC)↗[عمومی]
• UK SmPC Fortacin — Fortacin 150 mg/ml + 50 mg/ml cutaneous spray (lidocaine/prilocaine) — Summary of Product Characteristics (Revised 14 November 2024)↗[عمومی]
• UK SmPC Otrivine 0.1% — Otrivine Blocked Nose Relief 0.1% w/v nasal spray (xylometazoline) — Summary of Product Characteristics (Revised 27 February 2024)↗[عمومی]
• UK SmPC Difflam rinse — Difflam 0.15% w/v Sore Throat Rinse (benzydamine) — Summary of Product Characteristics (Revised September 2025)↗[عمومی]
• UK SmPC Stugeron 15mg — Stugeron 15 mg tablets (cinnarizine) — Summary of Product Characteristics (Revised 19 December 2022)↗[عمومی]
• UK SmPC Phenobarb elixir — Phenobarbital Elixir BP 15 mg/5 mL — Summary of Product Characteristics (Revised 12 November 2021)↗[عمومی]
• UK SmPC Daktarin gel — Daktarin Oral Gel (miconazole 20 mg/g) — Summary of Product Characteristics (Revised 27 August 2026)↗[عمومی]
• UK SmPC Ilaxten 20mg — Ilaxten 20 mg tablets (bilastine) — Summary of Product Characteristics (Revised 11 February 2026)↗[عمومی]
• UK Dostinex SmPC — Dostinex (cabergoline) tablets — SmPC (Revised 09/2024)↗[عمومی]
• UK Dienogest 2 mg SmPC — Dienogest 2 mg tablets — SmPC (Revised 05/08/2024)↗[عمومی]
• UK Galvus SmPC — Galvus 50 mg tablets (vildagliptin) — SmPC (Revised 22 June 2023)↗[عمومی]
• eMC Arcoxia — Arcoxia (etoricoxib) 30/60/90/120 mg film-coated tablets — SmPC (Revised 19 March 2025)↗[عمومی]
• eMC Circadin — Circadin (melatonin) 2 mg prolonged-release tablets — SmPC (Revised 1 January 2021)↗[عمومی]
• eMC Typhim Vi — Typhim Vi (typhoid Vi polysaccharide vaccine) — SmPC (Revised 4 January 2025)↗[عمومی]
• eMC Synagis — Synagis (palivizumab) 50 mg/0.5 mL and 100 mg/1 mL — SmPC (Revised 26 March 2024)↗[عمومی]
• eMC Valdoxan — Valdoxan (agomelatine) 25 mg film-coated tablets — SmPC (Revised 15 April 2026)↗[عمومی]

SmPC اروپا (EMA)

• EMA Priligy leaflet — Priligy (dapoxetine) — EMA Article 29 referral, Annex III: labelling and package leaflet↗[عمومی]

گایدلاین منتشرشده

• FDA DSC 2018 — FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older (Safety Announcement 2018-01-11)↗[عمومی]
• CPS AOM 2016 — Management of acute otitis media in children six months of age and older. Le Saux N, Robinson JL. Paediatr Child Health 2016;21(1):39-44 (Reaffirmed 2024-11-21)↗[عمومی]
• CPS Ondansetron 2018 — Emergency department use of oral ondansetron for acute gastroenteritis-related vomiting in infants and children. Cheng A; updated by Doré-Bergeron MJ, Chauvin-Kimoff L. Practice point, posted 2018-12-19↗[عمومی]
• CPS Croup — Acute management of croup in the emergency department. Ortiz-Alvarez O. Practice point; posted 2017-05-24, updated 2026-03-06↗[عمومی]
• WHO/USAID Diarrhoea 2005 — Diarrhoea Treatment Guidelines including new recommendations for the use of ORS and zinc supplementation for clinic-based healthcare workers (January 2005)↗[عمومی]
• WHO eLENA Zinc — Zinc supplementation in the management of diarrhoea (WHO e-Library of Evidence for Nutrition Actions) (Last updated 2023-08-09)↗[عمومی]
• WHO Fact sheet — Diarrhoeal disease — WHO fact sheet (7 March 2024)↗[عمومی]

منبع دارای مجوز دانشکده

• Licensed ref — Licensed pediatric dosing reference (pending, via medical school license)[در انتظار مجوز]

بروشور ایران (IFDA)

هنوز منبعی از این نوع ثبت نشده است.

کتاب مرجع

هنوز منبعی از این نوع ثبت نشده است.

MedlinePlus (کتابخانه ملی پزشکی آمریکا)

• MedlinePlus — MedlinePlus Medical Encyclopedia: Ear infection - acute (Review date 2025-01-01)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Strep throat (Review date 2025-07-03)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Community-acquired pneumonia in adults (Review date 2024-08-19)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Sinusitis (Review date 2026-04-29)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Allergic rhinitis (Review date 2026-01-20)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Constipation in infants and children (Review date 2024-07-31)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Autism spectrum disorder (Review date 2025-04-06)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Schizophrenia (Review date 2024-07-17)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Bipolar disorder (Review date 2024-07-17)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Juvenile idiopathic arthritis (Review date 2025-04-01)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Cellulitis (Review date 2025-04-01)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Impetigo (Review date 2024-10-13)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Osteomyelitis (Review date 2026-03-01)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Urinary tract infection - children (Review date 2026-01-01)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Gonorrhea (Review date 2025-05-22)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Pertussis (Review date 2025-07-01)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Shigellosis (Review date 2026-03-01)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Pneumocystis jirovecii pneumonia (Review date 2025-12-13)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Amebiasis (Review date 2024-08-29)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Peptic ulcer (Review date 2025-04-21)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Gastroesophageal reflux disease - children (Review date 2024-07-31)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Giardia infection (Review date 2026-03-01)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Cryptosporidium enteritis (Review date 2026-03-01)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Viral gastroenteritis (stomach flu) (Review date 2026-04-27)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Generalized anxiety disorder (Review date 2025-04-19)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Hives (Review date 2025-04-01)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Asthma in children (Review date 2025-04-06)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Thrush - children and adults (Review date 2025-08-05)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Irritable bowel syndrome (Review date 2025-04-21)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Amebic liver abscess (Review date 2025-05-12)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Acute bronchitis (Review date 2026-02-27)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Flu (Review date 2024-07-23)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Chickenpox (Review date 2025-07-01)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Scabies (Review date 2025-11-20)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Pinworms (Review date 2024-10-09)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Ascariasis (Review date 2024-11-10)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Hookworm infection (Review date 2025-08-05)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Whipworm infection (Review date 2024-11-10)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Cysticercosis (Review date 2025-12-13)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Iron deficiency anemia (Review date 2025-04-01)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Rickets (Review date 2024-07-16)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Croup (Review date 2026-01-01)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Type 2 diabetes (Review date 2025-01-10)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Hypothyroidism (Review date 2024-07-21)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Osteoarthritis (Review date 2026-04-09)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Rheumatoid arthritis (Review date 2025-01-28)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Attention deficit hyperactivity disorder (Review date 2026-05-15)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Major depression (Review date 2025-04-19)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Obsessive-compulsive disorder (Review date 2026-05-15)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Panic disorder (Review date 2026-05-15)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Post-traumatic stress disorder (Review date 2026-05-15)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Social anxiety disorder (Review date 2026-05-15)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Bulimia (Review date 2026-05-15)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Tourette syndrome (Review date 2026-01-27)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Epilepsy (Review date 2025-04-16)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Migraine (Review date 2025-02-11)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Generalized anxiety disorder (Review date 2025-04-19)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Seasonal affective disorder (Review date 2026-05-15)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Trigeminal neuralgia (Review date 2026-05-04)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Psychosis (Review date 2026-05-15)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Essential tremor (Review date 2026-05-04)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Conjunctivitis or pink eye (Review date 2024-07-09)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Allergic conjunctivitis (Review date 2024-07-22)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Common cold (Review date 2025-01-01)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Heart failure (Review date 2024-07-14)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Atrial fibrillation and atrial flutter (Review date 2025-01-01)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Hyperthyroidism (Review date 2024-07-21)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Type 1 diabetes (Review date 2025-01-10)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Vaginal yeast infection (Review date 2025-08-18)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Fungal nail infection (Review date 2024-10-13)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Herpes - oral (Review date 2025-07-03)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Genital herpes (Review date 2025-07-03)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Shingles (Review date 2024-11-10)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Syphilis (Review date 2024-08-29)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Meningitis (Review date 2024-11-10)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Typhoid fever (Review date 2025-05-12)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Gout (Review date 2025-04-01)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Fibromyalgia (Review date 2025-01-28)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Insomnia (Review date 2026-05-15)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Meniere disease (Review date 2025-07-17)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Enlarged prostate (Review date 2025-07-01)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Urge incontinence (Review date 2025-07-01)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Chronic obstructive pulmonary disease (COPD) (Review date 2025-04-10)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Ringworm of the body (Review date 2024-10-13)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Tinea versicolor (Review date 2024-10-14)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Seborrheic dermatitis (Review date 2025-04-01)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Burns (Review date 2026-04-09)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Absent menstrual periods - secondary (Review date 2026-05-29)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Abnormal uterine bleeding (Review date 2024-10-15)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Osteoporosis (Review date 2025-01-28)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Deep vein thrombosis (Review date 2025-04-01)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Swimmer's ear (Review date 2024-07-16)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Trichomoniasis (Review date 2024-11-10)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Ringworm of the scalp (Review date 2024-10-13)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Helicobacter pylori infection (Review date 2026-01-13)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Alzheimer disease (Review date 2026-01-27)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Parkinson disease (Review date 2026-01-27)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Restless legs syndrome (Review date 2025-07-17)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Erection problems (Review date 2025-10-01)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Endometriosis (Review date 2025-05-22)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Acne (Review date 2025-08-02)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Psoriasis (Review date 2024-08-05)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Ear wax (Review date 2026-04-29)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Anaphylaxis (Review date 2026-01-20)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Septic shock (Review date 2025-12-13)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Cardiogenic shock (Review date 2026-06-01)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Stroke (Review date 2025-04-16)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Pulmonary embolus (Review date 2025-10-21)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Metabolic acidosis (Review date 2025-10-01)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Low blood potassium (Review date 2025-05-19)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Low blood sodium (Review date 2025-05-19)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Brucellosis (Review date 2025-08-05)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Low back pain - acute (Review date 2026-06-27)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Sprains (Review date 2025-04-01)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Tendinitis (Review date 2024-07-23)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Tension headache (Review date 2025-10-27)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Measles (Review date 2024-07-16)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Hemorrhoids (Review date 2025-07-22)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Anal fissure (Review date 2026-04-11)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Blepharitis (Review date 2024-08-05)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Vitiligo (Review date 2026-04-09)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Molluscum contagiosum (Review date 2025-04-01)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Acromegaly (Review date 2025-04-24)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Carcinoid syndrome (Review date 2024-07-29)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Peritonitis - secondary (Review date 2026-04-27)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Hospital-acquired pneumonia (Review date 2025-07-25)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Bipolar disorder (Review date 2024-07-17)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Schizoaffective disorder (Review date 2026-05-15)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Neurogenic bladder (Review date 2026-05-04)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Plague (Review date 2025-05-12)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Chancroid (Review date 2025-08-05)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Lymphogranuloma venereum (Review date 2025-08-05)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Donovanosis (granuloma inguinale) (Review date 2025-08-05)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Pubic lice (Review date 2024-10-13)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Genital warts (Review date 2024-10-15)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Black widow spider (Review date 2025-07-01)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Brown recluse spider (Review date 2025-07-01)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Scorpions (Review date 2025-07-01)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Snake bites (Review date 2025-10-14)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Mucormycosis (Review date 2024-11-10)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Amyotrophic lateral sclerosis (ALS) (Review date 2026-05-04)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Huntington disease (Review date 2025-04-16)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Tardive dyskinesia (Review date 2026-05-04)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Duchenne muscular dystrophy (Review date 2025-10-27)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Multiple sclerosis (Review date 2026-01-27)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Lambert-Eaton myasthenic syndrome (Review date 2026-05-04)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Hypokalemic periodic paralysis (Review date 2025-10-23)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Psoriatic arthritis (Review date 2025-01-28)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Transplant rejection (Review date 2025-04-01)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Non-Hodgkin lymphoma (Review date 2025-02-03)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Pemphigus vulgaris (Review date 2026-04-09)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Prostate cancer (Review date 2025-07-01)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Chronic myelogenous leukemia (CML) (Review date 2026-01-29)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Colorectal cancer (Review date 2025-04-01)↗[عمومی]
• MedlinePlus — MedlinePlus Medical Encyclopedia: Narcolepsy (Review date 2025-07-17)↗[عمومی]

وب‌سایت دارویی (منبع ثانویه، نامطمئن)

• Salamati24 Corizan — کوریزان کودکان سرماخوردگی و آنفلوانزا — صفحه دارو↗[عمومی]
• Adorateb Corizan — شربت کوریزان سرماخوردگی و آنفولانزا — صفحه محصول↗[عمومی]
• Darooyab Ketotifen — کتوتیفن — موارد مصرف، دوز، اشکال دارویی↗[عمومی]
• Darooyab Theophylline G — تئوفیلین جی — دارویاب↗[عمومی]
• Beytoote Bromhexine — کاربردهای شربت برم هگزین و عوارض و دوز مصرفی آن↗[عمومی]
• Darooyab Biperiden — بی‌پریدن — موارد مصرف، اشکال دارویی، نام‌های تجاری↗[عمومی]
• Darooyab Dydrogesterone — دیدروژسترون — موارد مصرف، اشکال دارویی، نام‌های تجاری↗[عمومی]
• Darooyab Aluminium MGS — آلومینیوم ام جی اس — موارد مصرف، اشکال دارویی↗[عمومی]
• Darooyab Vitamin A+D — ویتامین آ + د خوراکی — موارد مصرف، اشکال دارویی↗[عمومی]
• Darooyab Eternavit AD — قطره آ د اترنیویت ۳۰ میلی‌لیتر↗[عمومی]
• Darooyab B Complex — ویتامین ب کمپلکس — موارد مصرف، اشکال دارویی↗[عمومی]
• Darooyab Contracep. HD — کنتراسپتیو اچ دی — موارد مصرف، اشکال دارویی↗[عمومی]
• Darooyab Aburaihan — داروسازی ابوریحان — فهرست فرآورده‌ها (شیاف ایبوپروفن)↗[عمومی]
• Darooyab — Darooyab — Iranian generic drug pages (IFDA generic codes, registered dosage forms and brands)↗[عمومی]
• Darooyab Trimetazidine — تری‌متازیدین — موارد مصرف و اشکال دارویی↗[عمومی]
• Darooyab Flunarizine — فلوناریزین — موارد مصرف، منع مصرف و اشکال دارویی↗[عمومی]
• Darooyab Cloxacillin — کلوگزاسیلین — موارد مصرف، مصرف در بارداری و اشکال دارویی↗[عمومی]
• Darooyab Penicillin 633 — پنی‌سیلین ۶.۳.۳ — موارد مصرف، منع مصرف و اشکال دارویی↗[عمومی]
• Darooyab Adult cold — سرماخوردگی بزرگسالان — موارد مصرف، ترکیب‌ها و اشکال دارویی↗[عمومی]
• Darooyab Antihist-Decong — آنتی‌هیستامین دکونژستانت — موارد مصرف و اشکال دارویی↗[عمومی]
• Darooyab Albendazole — آلبندازول — اشکال دارویی (سوسپانسیون ۴۰۰ mg/۱۰ mL)↗[عمومی]
• Darooyab Furazolidone — فورازولیدون — موارد مصرف، منع مصرف، تداخلات و اشکال دارویی↗[عمومی]
• Darooyab Glucantime — مگلومین آنتی موان — موارد مصرف، منع مصرف و اشکال دارویی↗[عمومی]
• Darooyab Antiscorpion — ضدسم عقرب — موارد مصرف، هشدارها و اشکال دارویی↗[عمومی]
• Darooyab Antisnake — ضدسم مار — موارد مصرف، هشدارها و اشکال دارویی↗[عمومی]
• Darooyab Streptokinase — استرپتوکیناز — موارد مصرف، منع مصرف و اشکال دارویی↗[عمومی]